WO2015141365A1 - Catheter assembly - Google Patents

Catheter assembly Download PDF

Info

Publication number
WO2015141365A1
WO2015141365A1 PCT/JP2015/054541 JP2015054541W WO2015141365A1 WO 2015141365 A1 WO2015141365 A1 WO 2015141365A1 JP 2015054541 W JP2015054541 W JP 2015054541W WO 2015141365 A1 WO2015141365 A1 WO 2015141365A1
Authority
WO
WIPO (PCT)
Prior art keywords
slit
plug
catheter assembly
catheter
insertion member
Prior art date
Application number
PCT/JP2015/054541
Other languages
French (fr)
Japanese (ja)
Inventor
石田昌弘
Original Assignee
テルモ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テルモ株式会社 filed Critical テルモ株式会社
Priority to JP2016508605A priority Critical patent/JPWO2015141365A1/en
Publication of WO2015141365A1 publication Critical patent/WO2015141365A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/06Body-piercing guide needles or the like
    • A61M25/0606"Over-the-needle" catheter assemblies, e.g. I.V. catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0097Catheters; Hollow probes characterised by the hub
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02Access sites
    • A61M39/06Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
    • A61M39/0693Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof including means for seal penetration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02Access sites
    • A61M39/06Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
    • A61M2039/0633Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof the seal being a passive seal made of a resilient material with or without an opening
    • A61M2039/064Slit-valve
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/06Body-piercing guide needles or the like
    • A61M25/0612Devices for protecting the needle; Devices to help insertion of the needle, e.g. wings or holders
    • A61M25/0618Devices for protecting the needle; Devices to help insertion of the needle, e.g. wings or holders having means for protecting only the distal tip of the needle, e.g. a needle guard

Definitions

  • the present invention relates to a catheter assembly that enables infusion to a patient by being inserted and placed in a patient's blood vessel, for example.
  • a catheter assembly including an outer needle (catheter), an inner needle penetratingly disposed in the catheter, and a hub that holds the proximal end side of the catheter is used.
  • the catheter and the inner needle are punctured integrally into the blood vessel of the patient, and after the puncture, only the inner needle is withdrawn, the catheter and the hub are left on the patient side, and the hub and the infusion tube are connected.
  • This type of catheter assembly is provided with a hemostasis valve (valve element) for preventing blood leakage and a cylindrical insertion member in the hub in order to improve the connectivity of the infusion tube (for example, JP-A-2002-263197). See the official gazette). That is, when the infusion tube is connected, the insertion member is pushed by the connector of the infusion tube to penetrate the slit of the hemostasis valve, and the distal end side hollow portion and the proximal end side hollow portion are communicated with each other than the hemostasis valve. Thereby, the infusion agent supplied from the infusion tube flows into the patient via the catheter assembly.
  • a hemostasis valve valve element
  • the infusion tube connected to the catheter assembly may be replaced in order to infuse different types of infusion agents.
  • the catheter assembly pushes back the insertion member with a coil spring provided in the hub after the infusion tube is removed, so that the slit of the hemostasis valve is formed. It is convenient to re-occlude. This is because when the hemostasis valve is re-occluded, blood leakage is suppressed when the infusion tube is replaced.
  • the insertion member is formed thicker than the inner needle in order to allow the infusion agent to flow reliably into the distal end side hollow portion. Therefore, once the insertion member passes through the hemostasis valve, the catheter assembly may not sufficiently re-slit the slit by the hemostasis valve. If the re-occlusion is insufficient, blood leaks from the proximal end of the hub, increasing the possibility of infection by blood, making it difficult to connect other infusion tubes, or poorly looking due to blood. Inconveniences such as become.
  • the present invention has been made in view of the above circumstances, and with a simple configuration, the slit of the valve body can be reclosed more reliably, blood leakage can be prevented, and tube replacement can be simplified. It is an object to provide a catheter assembly.
  • a catheter assembly comprises a catheter, a hub that holds the catheter and has a hollow portion that communicates with a hole portion of the catheter, the hole portion and the hollow portion.
  • An inner needle that can be inserted; an insertion member that is displaceably disposed in the hollow portion; and a valve body that is provided in the hollow portion.
  • the valve body includes an inner needle slit through which the inner needle is inserted. And an insertion member slit through which the insertion member is inserted.
  • the valve body of the catheter assembly since the valve body of the catheter assembly has the two slits of the inner needle slit and the insertion member slit, the valve body slit can be reclosed more reliably. That is, since the valve body has the slit for the insertion member, the insertion member can be easily passed through and displaced, and the damage to the slit for the insertion member can be reduced. Further, even if the inner needle slit is formed to be small according to the diameter of the inner needle, the valve body is not forced to spread, and the valve body can maintain a strong closed state. Therefore, the catheter assembly can prevent the leakage of blood and simplify the replacement of the tube.
  • the insertion member includes a closing portion that closes the slit for the insertion member, and an opening portion that opens to the slit due to a different shape or phase with respect to the closing portion connected to the proximal end side of the closing portion, It is preferable that either one of the closing part or the opening part is always inserted into the insertion member slit.
  • either one of the blocking portion or the opening portion is always inserted into the insertion member slit, so that the valve body and the blocking portion cooperate with each other at a position where the blocking portion overlaps the insertion member slit.
  • the hollow part is effectively blocked. Therefore, blood leakage can be prevented more reliably.
  • the insertion member slit can be opened to allow the liquid to flow easily.
  • the cross-sectional shape of the open portion may be substantially similar to the cross-sectional shape of the closed portion, and the phase may be shifted by about 90 ° around the axis of the insertion member with respect to the closed portion.
  • the phase of the cross-sectional shape of the open portion is shifted by approximately 90 ° relative to the closed portion, so that when the open portion is inserted into the insert member slit, the insert member slit extending in a predetermined direction can be sufficiently expanded. Can do. Therefore, the liquid can pass through the insertion member slit more easily.
  • the front opening may have a flow hole that is longer in the axial direction than the thickness of the blocking membrane provided with the insertion member slit of the valve body.
  • the opening portion has a flow hole that is longer in the axial direction than the thickness of the obstruction membrane, so that the liquid can be discharged from the valve body through the flow hole in a state where the flow hole is disposed at a position overlapping the slit. It can flow into the hollow portion on the tip side.
  • the closed portion and the open portion have the same thickness in the direction orthogonal to the extending direction of the insertion member slit.
  • the insertion member may always be inserted into the insertion member slit, and the insertion member may have a deformable portion that is elastically deformable in a direction orthogonal to the extending direction of the insertion member slit.
  • the deforming portion of the insertion member that is always inserted into the insertion member slit can be elastically deformed in a direction orthogonal to the extending direction of the insertion member slit, so that the insertion member is deformed along with the deformation of the deformation portion.
  • the slit can be easily opened.
  • the deforming portion is formed in a plate shape and extends in the axial direction, and one end of the insertion member receives a pressing force from a connector connected to the hub in a curved manner connected to the deforming portion. It is preferable that the receiving part which can be formed is formed.
  • the receiving portion is formed at one end of the insertion member, the plate-shaped deformation portion can be easily deformed by the pressing force from the connector, and the insertion member slit can be opened.
  • the inner needle slit and the insertion member slit are formed in parallel, and the cutting width of the insertion member slit is longer than the cutting width of the inner needle slit.
  • the slit width for the insertion member slit is longer than the slit width for the inner needle slit and is formed in parallel, so that the valve body may crack when the insertion member slit is opened. Even if it is generated, it is possible to suppress the crack from going to the inner needle slit. Therefore, the obstruction
  • the catheter assembly of the present invention it is possible to more easily reclose the slit of the valve body with a simple configuration, prevent blood leakage, and simplify tube replacement.
  • FIG. 2 is an exploded perspective view showing a part of the catheter assembly of FIG. 1.
  • 3A is a side sectional view showing a part of the catheter assembly of FIG. 1
  • FIG. 3B is a sectional view taken along line IIIB-IIIB of FIG. 3A.
  • 5A is a first perspective view showing the plug of the catheter assembly of FIG. 2
  • FIG. 5B is a second perspective view showing the plug of the catheter assembly of FIG.
  • FIG. 2 is a plan sectional view showing a part of the catheter assembly of FIG. 1.
  • FIG. 7A is a plan sectional view showing a state where the connector of the infusion tube is connected to the catheter assembly of FIG. 6, and FIG. 7B is a sectional view taken along the line VIIB-VIIB in FIG. 7A. It is side surface sectional drawing which shows the valve mechanism of the conventional catheter assembly roughly.
  • 9A is a plan sectional view showing a state where the connector of the infusion tube is detached from the catheter assembly of FIG. 7A
  • FIG. 9B is a sectional view taken along line IXB-IXB in FIG. 9A.
  • FIG. 10A is a side sectional view showing a part of the catheter assembly according to the second embodiment
  • FIG. 10B is a plan sectional view showing a part of the catheter assembly of FIG. 10A.
  • FIG. 11A is a first perspective view showing the plug of the catheter assembly of FIG. 10A
  • FIG. 11B is a second perspective view showing the plug of the catheter assembly of FIG. 10A
  • 12A is a plan sectional view showing a state where the connector of the infusion tube is connected to the catheter assembly of FIG. 10A
  • FIG. 12B is a sectional view taken along the line XIIB-XIIB of FIG. 12A
  • 13A is a plan sectional view showing a state where the connector of the infusion tube is detached from the catheter assembly of FIG. 12A
  • FIG. 13B is a sectional view taken along line XIIIB-XIIIB in FIG. 13A.
  • FIG. 14A is a side sectional view showing a part of the catheter assembly according to the third embodiment
  • FIG. 14B is a sectional view taken along line XIVB-XIVB in FIG. 14A
  • 15A is a first perspective view showing the plug of the catheter assembly of FIG. 14A
  • FIG. 15B is a second perspective view showing a state where the plug of the catheter assembly of FIG. 14A is elastically deformed.
  • 16A is a plan sectional view showing a state where the connector of the infusion tube is connected to the catheter assembly of FIG. 14A
  • FIG. 16B is a sectional view taken along the line XVIB-XVIB of FIG. 16A
  • 17A is a plan sectional view showing a state where the connector of the infusion tube is detached from the catheter assembly of FIG. 16A
  • FIG. 17B is a sectional view taken along line XVIIB-XVIIB in FIG. 17A.
  • the catheter assembly 10 includes a catheter 12 (outer needle), a catheter hub 14 that connects and holds the proximal end of the catheter 12, and an inner portion that is disposed through the catheter 12.
  • a needle 16 and an inner needle hub 18 that holds the proximal end of the inner needle 16 are provided.
  • a user such as a doctor or nurse grasps the inner needle hub 18 of the catheter assembly 10 and punctures the distal end portion of the blood vessel of the patient.
  • the distal end portion of the catheter assembly 10 has the catheter 12 and the inner needle 16 overlapped at the time of puncturing (hereinafter also referred to as a puncturable state), and is inserted integrally into the blood vessel of the patient.
  • a puncturable state the proximal end side of the catheter hub 14 and the distal end side of the inner needle hub 18 are connected, and the inner needle hub 18 supports the catheter hub 14.
  • the user pulls out the inner needle hub 18 in the proximal direction (retreats), thereby detaching the inner needle hub 18 from the catheter hub 14.
  • the inner needle 16 held by the inner needle hub 18 is also pulled out and detached from the catheter 12 and the catheter hub 14. That is, the inner needle 16 is removed from the patient's blood vessel. Therefore, on the patient side, the distal end side of the catheter 12 is inserted into the blood vessel, and the proximal end side of the catheter 12 and the catheter hub 14 are placed on the skin.
  • an infusion solution (medical solution) is administered from the infusion tube to the patient by connecting the connector 20 (see FIG. 7A) of the infusion tube to the proximal end side of the catheter hub 14.
  • the configuration of the catheter assembly 10 will be specifically described.
  • the catheter 12 is a tubular member that is flexible and has a predetermined length.
  • a lumen 12 a extending in the axial direction is formed inside the catheter 12.
  • the inner cavity 12a is set to an inner diameter through which the inner needle 16 can be inserted.
  • the constituent material of the catheter 12 is not particularly limited, but a resin material, particularly a soft resin material, is suitable.
  • a resin material particularly a soft resin material
  • PTFE polytetrafluoroetherene
  • ETFE ethylene-tetrafluoroethylene copolymer
  • Fluorinated resins such as bellfluoroalkoxy fluororesin (PFA), olefinic resins such as polyethylene and polypropylene, or mixtures thereof, polyurethane, polyester, polyamide, polyether nylon resin, the olefinic resin and ethylene-vinyl acetate Examples thereof include a mixture with a polymer.
  • the catheter 12 may have transparency so that the whole or a part of the inside can be visually recognized. Accordingly, it is possible to visually confirm a phenomenon (also referred to as flashback) in which blood flows into the catheter hub 14 through the lumen 12a of the catheter 12 with the catheter 12 inserted into the blood vessel.
  • a phenomenon also referred to as flashback
  • the proximal end portion of the catheter 12 is fixed to the distal end portion in the catheter hub 14 by an appropriate joining method such as caulking, fusion (thermal fusion, high frequency fusion, etc.), adhesion with an adhesive, or the like.
  • the catheter assembly 10 according to the first embodiment holds the catheter 12 between the inner surface of the catheter hub 14 by a caulking pin (not shown).
  • the catheter hub 14 that holds the catheter 12 is formed in a cylindrical shape that tapers in the distal direction.
  • the catheter hub 14 is interposed between the catheter 12 and the infusion tube so that both members can be connected (communicated) easily and reliably.
  • An operation protrusion 14 a for pushing the catheter 12 into the blood vessel is formed on the upper portion of the catheter hub 14.
  • the catheter hub 14 is exposed on the patient's skin in a state where the catheter 12 is punctured into a blood vessel, and is affixed with a tape or the like.
  • the catheter hub 14 is preferably made of a material harder than the catheter 12.
  • the constituent material of the catheter hub 14 is not particularly limited.
  • a thermoplastic resin such as polycarbonate, polyamide, polysulfone, polyarylate, methacrylate-butylene-styrene copolymer can be suitably used.
  • the inside of the catheter hub 14 is provided with a hollow portion 22 that is formed so as to penetrate in the axial direction and through which an infusion solution can flow.
  • the hollow portion 22 communicates with the proximal end opening 14b of the catheter hub 14, and as shown in FIG. 2, the hemostasis valve 24 (valve element), the seal member 26, the spring 28 (elastic member), the plug 30 ( Insertion member) is accommodated.
  • the hemostasis valve 24 valve element
  • the seal member 26 the spring 28
  • the plug 30 Insertion member
  • the inner needle 16 of the catheter assembly 10 is formed as a tubular member having rigidity capable of puncturing the patient's skin.
  • the constituent material of the inner needle 16 include a metal material such as stainless steel, aluminum, an aluminum alloy, titanium, or a titanium alloy.
  • the inner needle 16 is formed to be sufficiently longer than the catheter 12, and is configured such that a sharp needle tip 16a protrudes from the distal end opening of the catheter 12 in a puncturable state.
  • the posture of the inner needle 16 is such that the body portion passes through the hollow portion 22 of the catheter hub 14 and the proximal end portion connected to the body portion is fixed and held by an inner needle holding member (not shown) in the inner needle hub 18. Maintained.
  • the inner needle 16 is inserted from the proximal end side of the catheter hub 14.
  • the distal end of the catheter 12 is opened before the inner needle hub 18 is connected. It is preferable to insert the proximal end of the inner needle 16 from the top.
  • the needle tip 16a can be prevented from sticking into the catheter hub 14, the hemostasis valve 24, and the seal member 26, and the inner needle 16 can be assembled smoothly.
  • the inner needle hub 18 that holds the inner needle 16 is formed in a long casing that can be gripped by the user and stably operate the double tube body of the catheter 12 and the inner needle 16. Yes.
  • a housing mechanism (not shown) that houses the inner needle 16 when the inner needle hub 18 is detached from the catheter hub 14 is provided.
  • the double structure of the catheter 12 and the inner needle 16, the catheter hub 14 and the inner needle hub 18 are sequentially connected from the distal end side in the axial direction so that they can be handled integrally. ing.
  • a spring 28, a hemostatic valve 24, a seal member 26, and a plug 30 are appropriately disposed in the hollow portion 22 of the catheter hub 14, as shown in FIG. 3A.
  • the hollow portion 22 of the catheter hub 14 includes a catheter connection portion 32, a guide portion 34, a valve placement portion 36, and a connector connection portion 38 from the distal end side toward the proximal end side.
  • the catheter connection portion 32 is configured by an inner wall 32a that substantially matches the outer diameter of the catheter 12 at the distal end portion of the catheter hub 14.
  • the proximal end portion of the catheter 12 is firmly fixed by the inner wall 32a of the catheter connection portion 32 and a caulking pin.
  • the guide portion 34 is formed so that the distal end side is connected to the catheter connecting portion 32 and the infusion agent supplied from the proximal end side is guided to the lumen 12 a of the catheter 12.
  • the inner wall 34a constituting the guide portion 34 is formed in a tapered surface (funnel shape) in which the inner diameter on the distal end side becomes smaller toward the inner cavity 12a.
  • a spring 28 is disposed in the guide portion 34.
  • the spring 28 is formed in a spiral shape and is disposed so as to be sandwiched between the inner wall 34a of the catheter hub 14 (the tapered surface of the guide portion 34) and a plug 30 described later.
  • the spring 28 is formed in a diameter that can be fitted into the tapered surface of the guide portion 34, and has a predetermined length in the axial direction (the length from the inner wall 34a that contacts one end to the front of the hemostasis valve 24).
  • the spring 28 is contracted in the axial direction when the connector 20 is inserted into the hollow portion 22 and the plug 30 is pushed in the distal direction, and biases the plug 30 in the proximal direction. Therefore, when the connector 20 is detached from the hollow portion 22, the spring 28 pushes the plug 30 back in the proximal direction according to the total length.
  • valve arrangement part 36 is connected to the guide part 34 at the tip side, and is constituted by an inner wall 36a having a slightly larger diameter than the inner wall 34a of the guide part 34. That is, a step is formed between the guide portion 34 and the valve placement portion 36.
  • the hemostatic valve 24 and the seal member 26 are arranged in the valve arrangement portion 36.
  • the hemostasis valve 24 is an elastic member formed in a bottomed cylindrical shape and has a function of blocking blood circulation.
  • the hemostasis valve 24 is disposed so as to divide the hollow portion 22 of the catheter hub 14 into a distal end side hollow portion 22a and a proximal end side hollow portion 22b.
  • the elastic material constituting the hemostasis valve 24 examples include various rubber materials such as natural rubber, isoprene rubber, butyl rubber, butadiene rubber, styrene-butadiene rubber, urethane rubber, nitrile rubber, acrylic rubber, fluorine rubber, and silicone rubber (In particular, those obtained by vulcanization), various elastomers such as urethane, polyester, polyamide, olefin, styrene, and other thermoplastic elastomers, or mixtures thereof. Since the hemostasis valve 24 is also related to the configuration of the plug 30 described later, a specific configuration will be described later.
  • a plurality of inner circumferential groove portions 40 are provided on the inner wall 36a of the valve arrangement portion 36 to which the hemostasis valve 24 is fixed.
  • the inner circumferential groove portion 40 is formed such that the tip portion cuts out a stepped portion between the guide portion 34 and the valve placement portion 36, and extends in the axial direction along the inner wall 36 a of the valve placement portion 36 from the tip portion. Yes.
  • the inner peripheral groove portion 40 moves the air present in the distal end side hollow portion 22a to the proximal end side hollow portion 22b.
  • a seal member 26 is attached to the proximal end side of the hemostasis valve 24.
  • the catheter assembly 10 has a configuration in which the hemostasis valve 24 and the seal member 26 are fitted to each other so as not to rotate.
  • a plurality (three in FIG. 2) of fitting grooves 24a are formed on the outer peripheral surface of the hemostasis valve 24, and a plurality of fittings corresponding to the fitting grooves 24a are formed on the seal member 26.
  • a protrusion 26a for insertion is formed.
  • the seal member 26 includes an insertion protrusion 26a, a proximal end tubular portion 44 that matches the inner diameter of the valve placement portion 36 on the proximal end side of the insertion protrusion 26a, and the proximal end tubular portion 44 in the axial direction. And a through hole 46 therethrough.
  • the proximal end cylinder portion 44 is disposed so as to close the inner circumferential groove portion 40 and to be in close contact with the inner wall 36 a of the valve placement portion 36. Thereby, the hemostasis valve 24 and the seal member 26 are firmly fixed in the catheter hub 14.
  • the seal member 26 is made of a material that allows gas to pass but does not allow liquid to pass.
  • a material constituting the seal member 26 for example, a material formed of a porous body such as a polyethylene sintered body can be suitably used. That is, the seal member 26 blocks the blood that has moved through the inner circumferential groove 40 while allowing the air that has moved through the inner circumferential groove 40 to escape in the proximal direction.
  • the connector connecting portion 38 of the catheter hub 14 is connected to the valve placement portion 36 at the distal end side and extends to the proximal end opening portion 14b of the catheter hub 14.
  • the connector connecting portion 38 is configured so that the connector 20 of the infusion tube can be fitted (inserted connection).
  • the inner wall 38a on the proximal end side of the connector connecting portion 38 is formed in a tapered shape having a slightly smaller diameter toward the distal end direction in order to improve the connectivity with the connector 20.
  • the plug 30 In the state where puncturing is possible, the plug 30 is disposed in the valve placement portion 36 and the connector connection portion 38 so as to be displaceable.
  • the plug 30 functions together with the hemostasis valve 24 as a valve mechanism that enables blocking of blood in the catheter assembly 10 and supply of an infusion solution.
  • the catheter assembly 10 is configured by appropriately configuring this valve mechanism to improve fluidity of the infusion solution and facilitate replacement of the infusion tube.
  • the configuration of the hemostasis valve 24 and the plug 30 according to the first embodiment will be specifically described.
  • the hemostasis valve 24 formed in a bottomed cylindrical shape includes a side peripheral portion 48 that is tightly fixed to the inner wall 36 a of the valve placement portion 36, and a bottom portion that continues to the distal end side of the side peripheral portion 48. And the occluding film 50 to be configured.
  • the occlusion film 50 of the hemostasis valve 24 is formed thicker than the side peripheral portion 48 and is easily elastically deformed.
  • An inner needle slit 52 for passing the inner needle 16 and a plug slit 53 for passing the plug 30 are formed in the closing film 50.
  • the inner needle slit 52 is located at the center of the occlusion membrane 50 and is formed with a sufficiently short cutting width that easily closes as the inner needle 16 is pulled out of the hemostasis valve 24.
  • the inner needle slit 52 is formed in a single line so as to penetrate in the thickness direction of the occlusion film 50 and is self-occluded by the elastic force of the hemostasis valve 24.
  • the plug slit 53 is also formed penetrating in the thickness direction of the blocking film 50.
  • the plug slit 53 is provided so as to be parallel to the cutting direction (left-right direction) of the inner needle slit 52 at a position shifted from the center of the blocking film 50 (inner needle slit 52).
  • the plug slits 53 are spaced apart from each other by a predetermined distance in the upward direction of the inner needle slit 52 and are formed to have a longer cut width than the inner needle slit 52.
  • the plug 30 is always inserted into the hemostasis valve 24 as described later. Therefore, the slit 53 for plugs is not particularly limited in terms of the cut shape as long as the closing film 50 can be sealed in cooperation with the plug 30.
  • the plug slit 53 may be opened in a state where the plug 30 is not inserted.
  • a lubricant that makes sliding of the inner needle 16 and the plug 30 good may be applied to the inner surface of the hemostasis valve 24 constituting the inner needle slit 52 and the plug slit 53.
  • the hemostasis valve 24 may be provided with breakage prevention means (for example, making the peripheral edge of the slit flexible, etc.) so that the plug slit 53 is not broken even when the plug 30 is inserted.
  • the plug 30 is pushed out by the connector 20 of the infusion tube and passes through the plug slit 53 of the hemostasis valve 24, thereby causing the infusion agent supplied from the infusion tube to flow into the distal end side hollow portion 22a.
  • the plug 30 is formed in a length that can exist over the guide portion 34, the valve placement portion 36, and the connector connection portion 38 of the catheter hub 14 in a state of penetrating the hemostasis valve 24 (see FIG. 3A).
  • the plug 30 has a closed head portion 54 (closed portion), an open body portion 56 (open portion), and a flange portion 58 in this order from the distal end side toward the proximal end side.
  • the closed head portion 54 and the open body portion 56 are provided at positions that are shifted radially outward with respect to the axial center of the plug 30 that passes through the center of the flange portion 58 and that their phases are shifted by 90 ° around the axial center.
  • the occlusion head 54 closes the plug slit 53 in the inserted state of the plug slit 53 of the hemostasis valve 24, that is, it can block the hollow portion 22 back and forth in cooperation with the hemostasis valve 24.
  • the closed head 54 has a substantially semicircular shape in a cross-sectional view (see FIG. 3B), and is formed in an axial length slightly longer than the film thickness of the occluded film 50 in a side cross-sectional view (see FIG. 3A). .
  • the cross-sectional area of the blocking head 54 may be set as appropriate according to the plug slit 53, but has a thickness that can push the plug slit 53 up and down to the extent that the blocking film 50 is not broken. Good.
  • the distal end portion of the closed head portion 54 is provided with a retaining portion 54 a that protrudes outward from the side peripheral surface of the closed head portion 54.
  • the retaining portion 54 a is prevented from being pulled out in the proximal direction by being caught by the mouth edge of the plug slit 53.
  • the front end surface of the closed head 54 has a large area and is formed flat by the retaining portion 54 a, and functions as a seat for receiving one end of the spring 28.
  • the configuration of the retaining portion 54a is not particularly limited. For example, a groove portion into which the lip of the plug slit 53 can enter can be formed on the surface of the closed head portion 54, or the closed head portion 54 itself. The same effect can be obtained by sufficiently increasing the cross-sectional area.
  • the open body portion 56 includes a connecting portion 64 that is continuous to the proximal end side of the closed head portion 54 and an extending portion 66 that is continuous to the proximal end side of the connecting portion 64 and extends to the flange portion 58.
  • the connecting portion 64 is a portion that smoothly continues toward the closed head portion 54 whose phase is shifted by 90 ° around the axial center with respect to the open body portion 56 (extending portion 66). Specifically, the lower side of the connecting portion 64 is inclined upward from the extending portion 66 toward the distal end side, and the side on the side facing the axial center of the connecting portion 64 is extended from the extending portion 66.
  • the closed head 54 is supported by inclining in the width direction toward the distal end side.
  • the extending portion 66 is formed in a semicircular shape that is substantially similar to the closed head portion 54 in a cross-sectional view, and its axial length is sufficiently longer than the connecting portion 64.
  • the extending portion 66 extends in parallel with the axial center of the plug 30 to support the closed head 54, and when the plug 30 is pushed in the distal end direction, the direction (vertical direction) is perpendicular to the extending direction of the plug slit 53.
  • the plug slit 53 is opened in the direction).
  • the flange portion 58 is formed in a disc shape that protrudes radially outward from the proximal side surface of the open body portion 56.
  • the flange portion 58 includes a plate portion 68 having a predetermined plate thickness, and a protruding edge portion 70 slightly extending in the proximal direction at the periphery of the plate portion 68.
  • a flow hole 72 that is formed to have a predetermined diameter and that circulates the infusion agent.
  • the open body portion 56 is connected to a position adjacent to the flow hole 72 on the front end surface of the plate portion 68.
  • the proximal end surface of the protruding edge 70 is a receiving portion that receives the distal end surface of the connector 20 of the infusion tube.
  • a pair of hole portions 74 are formed in the flange portion 58 across the plate portion 68 and the protruding edge portion 70.
  • the pair of holes 74 are formed in a substantially rectangular shape, and are provided at positions facing each other with the open body 56 interposed therebetween. The hole 74 acts to allow the infusion agent to flow into the proximal end side hollow portion 22b and to evacuate the air in the proximal end side hollow portion 22b during circulation of the infusate.
  • the plug 30 configured as described above is preferably formed of a relatively hard resin material so as to pass through the plug slit 53 of the hemostasis valve 24 by receiving the pushing force from the connector 20.
  • the constituent material of the plug 30 is not specifically limited, For example, what was mentioned by the constituent material of the catheter hub 14 is applicable. Further, a lubricant may be applied to the outer peripheral surface of the plug 30 in order to improve the slidability of the plug 30 with respect to the hemostasis valve 24.
  • the catheter assembly 10 is configured to restrict the rotation of the plug 30 by the through hole 46 of the seal member 26.
  • the through-hole 46 is connected to the central hole 76 for passing the inner needle 16 and the cross-sectional shape of the closed head 54 and the open body 56 of the plug 30 connected to the central hole 76.
  • a peripheral hole 78 cut out. That is, the peripheral hole portion 78 is formed such that two semicircular shapes (the first semicircular portion 78a and the second semicircular portion 78b) are shifted by 90 ° in the circumferential direction and partially overlap when viewed from the front. .
  • the plug 30 When the catheter assembly 10 is assembled, the plug 30 is inclined in the circumferential direction so that the closed head portion 54 is opposed to the first semicircular portion 78a and the open body portion 56 is opposed to the second semicircular portion 78b.
  • the plug 30 can be easily passed through the seal member 26.
  • the extension portion 66 of the plug 30 In the usable state of the catheter assembly 10, the extension portion 66 of the plug 30 is disposed in the first semicircular portion 78 a. Therefore, even if the plug 30 is pushed in the distal direction as the connector 20 is inserted and the extension 66 receives stress from the plug slit 53, the plug 30 is restricted from rotating counterclockwise in FIG.
  • the catheter assembly 10 accommodates the above-mentioned members in the catheter hub 14 by appropriately assembling the above members in order to configure a punctureable state.
  • the insertion protrusion 26 a of the seal member 26 is inserted into the insertion groove 24 a of the hemostasis valve 24 to integrate the hemostasis valve 24 and the seal member 26, and the base of the spring 28 previously accommodated in the hollow portion 22. Place on the end side. Further, the plug 30 and the inner needle 16 are accommodated so as to penetrate the occlusion membrane 50 of the hemostasis valve 24.
  • the plug 30 is inserted into the plug slit 53 and the plug slit 53 is closed by the closing head 54.
  • the distal end surface of the closed head 54 comes into contact with the extended spring 28, and the extending portion 66 is accommodated in the through hole 46 (first semicircular portion 78 a) of the seal member 26.
  • the inner needle 16 is also inserted into the inner needle slit 52, but the inner needle slit 52 is closed without a gap because the closing film 50 is pressed downward with the closing head 54 inserted.
  • the inner needle 16 constitutes a double tube with the catheter 12, and extends straight through the catheter hub 14 (parallel to the open body 56) and penetrates the flow hole 72. Then, it is firmly held by the inner needle holding member in the inner needle hub 18.
  • the catheter assembly 10 according to the first embodiment is basically configured as described above, and the operation and effect thereof will be described below.
  • a user When performing infusion to a patient, a user (doctor or nurse or the like) prepares the catheter assembly 10 in the above-described puncturable state.
  • the user operates the inner needle hub 18 of the catheter assembly 10 to puncture the catheter 12 and the inner needle 16 into the blood vessel of the patient. After puncturing, the inner needle 16 and the inner needle hub 18 are pulled out from the catheter 12 and the catheter hub 14.
  • the outer diameter of the inner needle 16 is sufficiently small, and the inner needle slit 52 is elastically closed when the inner needle 16 is pulled out from the inner needle slit 52 of the hemostasis valve 24.
  • the patient's blood flows into the distal end side hollow portion 22a through the lumen 12a of the catheter 12.
  • the air present in the distal end side hollow portion 22a is pushed out to the proximal end side by the inflow of blood, moves in the proximal end direction through the inner peripheral groove portion 40, and further passes through the seal member 26 to the catheter hub 14. From the base end opening 14b.
  • the blood is blocked from leaking in the proximal direction by the hemostasis valve 24 and the seal member 26 and stored in the distal end side hollow portion 22a.
  • an infusion tube connector 20 is inserted into the catheter hub 14 remaining on the patient's skin by pulling out the inner needle 16 and the inner needle hub 18.
  • the distal end portion of the connector 20 is formed into a tapered cylinder along the inner wall 38a of the connector connecting portion 38 of the catheter hub 14, and when the predetermined amount of the connector 20 is inserted into the hollow portion 22, the catheter hub 14 and the connector 20 are fitted. Match.
  • the tip surface of the connector 20 contacts the flange portion 58 of the plug 30 to push the plug 30 in the tip direction.
  • the spring 28 existing between the inner wall 34a of the catheter hub 14 (guide part 34) and the distal end surface of the closed head 54 is pushed by the plug 30 and contracts.
  • the plug 30 pushed in the distal direction is inserted into the slit 53 for the plug by inserting the connecting portion 64 on the proximal end side of the closed head 54 into the slit 53 for the plug along the shape of the side portion of the connecting portion 64.
  • 53 is opened in the vertical direction. That is, in FIG. 3B, the closed head 54 having a semicircular cross section that is long in the left-right direction and short in the up-down direction is pushed out to the plug slit 53 extending in the left-right direction. Then, the connecting portion 64 that gradually changes in the left-right direction and gradually changes in the up-down direction is inserted into the plug slit 53. Since the plug 30 is restricted from rotating counterclockwise in FIG. 7B by the shape of the through hole 46 formed in the seal member 26, the plug 30 can move in the axial direction satisfactorily.
  • the semicircular extension 66 having a 90 ° phase shift from the closed head 54 is inserted into the plug slit 53. Is done.
  • the plug slit 53 formed linearly in the left-right direction is expanded so as to be short in the left-right direction and long in the up-down direction, and is opened with a relatively large channel cross-sectional area.
  • the infusion agent supplied from the infusion tube easily passes through the plug slit 53.
  • the tip of the plug 82 is formed in a cylindrical shape.
  • the plug 82 forms a region (retention region 84) in which liquid (blood or infusion) is likely to stay around the hemostasis valve 80 in a penetrating state.
  • the infusate that flowed out from the plug 30 moved in the distal direction almost without going around the stay region 84, and the infusate and blood that flowed into the stay region 84 were stagnant and remained.
  • the catheter assembly 10 has a semicircular cross section formed at the distal end side of the hemostasis valve 24. Allow the agent to wrap around to the side. As a result, it is possible to suppress the occurrence of the stay region 84 in the guide portion 34.
  • the infusion agent is continuously supplied to the guide portion 34, so that it is easily guided to the lumen 12a of the catheter 12 and flows into the blood vessel of the patient.
  • the connector 20 may be detached from the catheter hub 14 by exchanging the infusion agent or the like according to the patient's condition or the like. In this case, the user retracts the connector 20 relative to the catheter hub 14 and pulls out the infusion tube.
  • the catheter assembly 10 is configured to automatically push back the plug 30 in the proximal direction as shown in FIGS. 9A and 9B as the connector 20 moves backward.
  • the connecting portion 64 is tapered, it can be removed relatively easily.
  • the closed head 54 of the plug 30 is positioned in the plug slit 53.
  • the retaining portion 54 a is caught by the obstruction film 50, so that the occlusion head 54 is prevented from coming off.
  • the plug slit 53 is pushed and widened by the closing head 54 without a gap, and the hemostasis valve 24 is reliably closed.
  • the obstruction film 50 is torn due to the insertion of the plug 30, the obstruction film 50 is closed by the spread of the obstruction head 54. Accordingly, it is possible to favorably avoid blood from leaking into the proximal end side hollow portion 22b of the hemostasis valve 24.
  • the hemostasis valve 24 has the two slits of the inner needle slit 52 and the plug slit 53, so that each slit of the hemostasis valve 24 is further layered. Re-occlusion can be ensured. That is, since the hemostasis valve 24 has the plug slit 53, the plug 30 can be easily passed through and displaced, thereby reducing the damage of the plug slit 53. Further, even if the inner needle slit 52 is formed to be small according to the diameter of the inner needle 16, the inner needle slit 52 is not forcibly expanded and the hemostasis valve 24 can maintain a strong closed state. Therefore, the catheter assembly 10 can prevent blood leakage and simplify replacement of the infusion tube.
  • either one of the closed head portion 54 or the open body portion 56 is always inserted into the plug slit 53, so that the hemostatic valve 24 and the closed head portion are positioned at a position where the closed head portion 54 overlaps the plug slit 53. 54 cooperate to effectively close the hollow portion 22. Therefore, blood leakage can be prevented more reliably.
  • the plug slit 53 can be opened to allow the liquid to flow easily.
  • the plug slit 53 extending in a predetermined direction when the open body portion 56 is inserted into the plug slit 53. Can be expanded sufficiently. Therefore, the infusion agent can pass through the plug slit 53 more easily. Furthermore, since the cut width of the plug slit 53 is longer than the cut width of the inner needle slit 52 and is formed in parallel, the hemostasis valve 24 is cracked when the plug slit 53 is opened. Even if it is generated, it is possible to suppress the crack from heading toward the inner needle slit 52. Therefore, the obstruction by the hemostasis valve 24 and the plug 30 can be further ensured.
  • the catheter assembly 10 is not limited to the first embodiment described above, and of course, various embodiments, modifications, and application examples can be taken.
  • the plug 30 in a state where the catheter assembly 10 can be punctured, the plug 30 may not be inserted into the plug slit 53 and may be in a standby state on the proximal end side of the hemostasis valve 24.
  • the catheter assembly 10A according to the second embodiment is different from the catheter assembly 10 according to the first embodiment in the configuration of each member disposed in the hollow portion 22 of the catheter hub 14. .
  • the same reference numerals are given to the same configuration or the same function as the catheter assembly 10 according to the first embodiment, and the detailed description thereof is omitted.
  • each configuration will be described with the inner needle hub 18 omitted, but of course the inner needle hub 18 according to the first embodiment can be applied.
  • the plug 130 assembled to the catheter assembly 10A is integrally formed with an elastic portion (spring portion 132) for pushing the plug 130 back in the proximal direction.
  • the hemostasis valve 24 in which the plug 130 is disposed can adopt the same configuration as the hemostasis valve 24 according to the first embodiment, and the inner needle slit 52 and the plug slit 53 are provided in the closing membrane 50. Yes.
  • the seal member 150 can form the through hole 152 in a circular cross section, and does not restrict the rotation of the plug 130. That is, the plug 130 is basically continuously inserted into the plug slit 53 of the hemostasis valve 24, so that the rotation is regulated by the hemostasis valve 24.
  • the seal member 26 may have a through hole corresponding to the cross-sectional shape of the inner needle 16 or the plug 130.
  • the plug 130 has a sufficient thickness as compared with the plug 30 according to the first embodiment, and has an axial length that is accommodated across the guide portion 34, the valve placement portion 36, and the connector connection portion 38 of the catheter hub 14.
  • a spring part 132, a closed head part 134, an open body part 136, and a flange part 138 are provided in order from the distal end side to the proximal end side.
  • the spring portion 132 of the plug 30 has a predetermined elastic force by connecting a plurality of (in the illustrated example, five) rings 140 along the axial direction of the catheter hub 14.
  • the ring 140 has a hole 140a penetratingly formed in the thickness direction, and is formed in an elliptical shape having a short axis in the axial direction and a long axis in the width direction in a plan view shown in FIG. 10B.
  • the ring 140 acts to release the stress in the major axis direction (width direction) and to be elastically crushed.
  • the entire spring portion 132 is sufficiently shortened in the axial direction.
  • the closed head 134 is connected to the proximal end side of the spring portion 132 and has a flat plate shape wider than the spring portion 132.
  • the occlusion head 134 has an axial length that is slightly longer than the film thickness of the occlusion membrane 50 in a side sectional view (see FIG. 10A).
  • a protruding portion 134 a (prevention portion) that prevents the plug 130 from coming out of the plug slit 53 is formed to protrude.
  • the open body portion 136 is connected to the proximal end side of the closed head portion 134 and has a flat plate shape extending in the proximal direction with the same width and thickness as the closed head portion 134.
  • a flow hole 142 that penetrates in the thickness direction is formed on the flat plate surface of the open body portion 136.
  • the flow hole 142 has a function of communicating the distal end side hollow portion 22 a and the proximal end side hollow portion 22 b in a state where the open body portion 136 is inserted into the plug slit 53.
  • the flow hole 142 is formed in a wide square shape on the front end side in a plan view, and is formed in a taper shape that gradually becomes narrower from the intermediate portion in the axial direction toward the base end side. Since the circulation hole 142 is wide on the distal end side, it is possible to sufficiently secure the circulation amount of the infusion agent. Moreover, the strength of the plug 130 can be increased because the flow hole 142 is narrow on the base end side.
  • the flange portion 138 is formed in a disk shape continuous to the proximal end side of the open body portion 136, and is configured to cause the infusion agent to flow up and down the open body portion 136 by further notching up and down.
  • the open body 136 is connected to a front end surface that is shifted upward with respect to the center of the flange 138, and a notch 144 on the lower side of the open body 136 can pass the inner needle 16. It is formed to a depth. As a result, the inner needle 16 is arranged in parallel with the plug 130 through the notch 144.
  • the catheter assembly 10A inserts the plug 130 into the plug slit 53 of the hemostasis valve 24 and closes the plug slit 53 with the closing head 134 in order to configure a punctureable state.
  • the spring portion 132 on the tip side of the closed head 134 just abuts against the inner wall 34 a of the guide portion 34 of the catheter hub 14.
  • the inner needle 16 is also inserted into the inner needle slit 52, but the inner needle slit 52 is closed without a gap because the closing film 50 is pressed downward with the closing head 134 inserted.
  • the catheter assembly 10A according to the second embodiment is basically configured as described above, and the operation and effect thereof will be described below.
  • the catheter assembly 10A is also operated in the same manner as the catheter assembly 10 according to the first embodiment. That is, in the puncture enabled state, the catheter assembly 10A is punctured by the patient with the catheter 12 and the inner needle 16 under the operation of the user, and then the inner needle 16 is withdrawn. When the inner needle 16 is pulled out, the plug 130 is inserted into the plug slit 53 of the hemostasis valve 24, so that the plug slit 53 is reliably closed and the inner needle slit 52 below the plug 130 is positively opened. Block. For this reason, even if blood flows into the hollow portion 22, the hemostasis valve 24 can satisfactorily block blood leakage.
  • the infusion tube connector 20 is inserted into the catheter hub 14 as shown in FIG. 12A.
  • the front end surface of the connector 20 comes into contact with the flange portion 138 of the plug 130 and pushes the plug 130 in the front end direction.
  • the spring portion 132 of the plug 130 is elastically deformed and contracts in the axial direction, and the closing head 134 moves in the distal direction relative to the closing membrane 50.
  • the plug 130 is pushed by the connector 20 until the tip end side of the flow hole 142 of the open body portion 136 exceeds the blocking membrane 50.
  • the flow hole 142 overlaps the plug slit 53 and the plug slit 53 is opened.
  • the plug 130 is formed to be thicker than the plug 30 according to the first embodiment, and the plug slit 53 is largely opened according to the thickness of the opening body 136.
  • the infusion agent supplied from the connector 20 can flow through the notch 144 into the proximal end side hollow portion 22b and further pass through the plug slit 53 through the flow hole 142.
  • the infusion agent flows out above and below the flat open body 136. For this reason, the infusion agent can be easily wrapped around the plug 130, and the occurrence of the stay region 84 (see FIG. 8) in the distal end side hollow portion 22a can be suppressed.
  • the infusate that has flowed into the distal end side hollow portion 22a is easily guided to the lumen 12a of the catheter 12 and flows into the blood vessel of the patient.
  • the spring portion 132 operates to return elastically. That is, the spring part 132 automatically pushes the plug 130 in the proximal direction, so that the open body part 136 comes out of the plug slit 53.
  • the closed head 134 is positioned in the plug slit 53.
  • the plug slit 53 is pushed open by the closing head 134 without a gap, and becomes sealed, and the hemostasis valve 24 and the plug 130 firmly close the hollow portion 22.
  • the obstruction film 50 with the obstruction head 134 being pushed and expanded can close the torn part. Accordingly, it is possible to favorably avoid blood from leaking into the proximal end side hollow portion 22b of the hemostasis valve 24.
  • the catheter assembly 10A according to the second embodiment can achieve the same effects as those of the catheter assembly 10 according to the first embodiment.
  • the catheter assembly 10 ⁇ / b> A has a flow hole 142 in which the open body 136 is longer in the axial direction than the thickness of the blocking membrane 50. Therefore, in a state where the open body 136 is inserted into the plug slit 53 and the flow hole 142 is overlapped with the plug slit 53, the proximal end side hollow portion 22 b and the distal end side hollow portion 22 a communicate with each other through the flow hole 142. Therefore, the infusion agent can easily flow into the distal end side hollow portion 22a through the circulation hole 142.
  • drum 136 is not limited to the flow hole 142 penetrated up and down,
  • drum 136 can also be employ
  • the catheter assembly 10A can reduce the number of parts, and can reduce the manufacturing cost and the work man-hour.
  • the configuration of the elastic portion that pushes back the plugs 30 and 130 of the catheter assemblies 10 and 10A is not particularly limited.
  • the spring portion 132 according to the second embodiment may be provided in the plug 30 according to the first embodiment.
  • the member for integrally forming the elastic portion is not limited to the plugs 30 and 130, and may be the catheter hub 14, the hemostasis valve 24, the seal members 26 and 150, or the like.
  • an elastic piece that protrudes from the inner wall 34 a of the guide portion 34 toward the distal end surface of the plug 30 may be used.
  • the elastic piece may be provided in the valve arrangement portion 36 or the connector connection portion 38 and elastically contact the flange portion 58 of the plug 30.
  • an elastic piece may be protruded from the base end part of the hemostatic valve 24 toward the flange part 58 of the plug 30.
  • the catheter assembly 10 ⁇ / b> A suppresses the sliding resistance of the plug 30 when the plug 30 is displaced relative to the plug slit 53 because the closed head 134 and the open body 136 have the same thickness. Can be moved smoothly.
  • the catheter assembly 10B according to the third embodiment is configured such that the configuration of each member disposed in the hollow portion 22 of the catheter hub 14 is according to the first and second embodiments. Different from 10, 10A. Specifically, the plug 160 assembled to the catheter assembly 10B is configured as a plate-like elastic member (plate spring).
  • the plug 160 is configured as a leaf spring, the spring 28 (see FIG. 2) cannot be accommodated in the catheter hub 14.
  • the hemostasis valve 24 according to the first embodiment and the seal member 150 according to the second embodiment are disposed at appropriate positions in the hollow portion 22 and penetrate through the hemostasis valve 24 and the seal member 150.
  • the plug 160 is accommodated.
  • the plug 160 extends in a sufficiently thin state so as to be easily elastically deformed compared to the plug 30 according to the first embodiment, and has an axial length extending between the guide portion 34, the valve disposing portion 36, and the connector connecting portion 38.
  • a distal end locking portion 162, an intermediate deformation portion 164, and a proximal end receiving portion 166 are provided from the distal end side toward the proximal end side.
  • the width in the left-right direction of the plug 160 is substantially equal to the width in the left-right direction (extending direction) of the plug slit 53, and the distal end locking portion 162, the intermediate deformation portion 164, and the base end receiving portion 166 are the same. It is formed in width.
  • the front end locking portion 162 is a portion that is locked to the inner wall 34a of the guide portion 34, and is formed to be bent downward as shown in FIGS. 15A and 15B.
  • the degree of curvature (curvature radius) of the distal end locking portion 162 is formed larger than the round corner of the proximal end receiving portion 166.
  • the distal end locking portion 162 has a pair of leg portions 162a formed in the downward direction by notching the intermediate portion in the width direction.
  • the tip ends of the pair of leg portions 162a are formed at an acute angle and are easily caught on the inner wall 34a formed in a tapered shape of the guide portion 34.
  • a space between the pair of legs 162a is an inverted U-shaped valley 162b wider than the lumen 12a of the catheter 12, and the inner needle 16 and the infusion solution can be easily passed.
  • the shape of the tip locking portion 162 is not particularly limited as long as the plug 160 is locked so that the plug 160 is elastically deformed in a predetermined direction.
  • the distal end locking portion 162 may extend substantially linearly without being curved, and may be locked to the inner wall 34 a of the guide portion 34.
  • the catheter hub 14 may be configured such that a locking projection (not shown) is projected (for example, integrally formed) in the distal end side hollow portion 22a so that the distal end locking portion 162 is hooked.
  • the intermediate deformation portion 164 is a portion that is connected to the proximal end side of the distal end locking portion 162 and has a shape memorized so as to draw a gentle arc shape in a side view.
  • the intermediate deformation part 164 is elastically deformed relatively easily by being formed thin in the axial direction with a thin plate thickness. That is, the intermediate deformation portion 164 is deformed so as to bend downward in a direction perpendicular to the surface direction of the leaf spring.
  • the catheter assembly 10B is configured to open the plug slit 53 downward based on the elastic deformation of the intermediate deformation portion 164 of the plug 160. Specifically, it is inserted so that the vicinity of the top portion 164 a of the intermediate portion in the axial direction of the intermediate deformable portion 164 overlaps the occlusion membrane 50 of the hemostasis valve 24. In the punctureable state where the plug 160 is not elastically deformed, the inserted intermediate deformation portion 164 is disposed at a position where the plugging membrane 50 is closed (so as not to provide an opening action at the initial formation position of the plug slit 53). Has been.
  • the plug 160 when the plug 160 is pushed in the distal direction, the intermediate deformation portion 164 becomes a bow, and the top portion 164a is displaced downward to push down the blocking membrane 50. As a result, the plug slit 53 is largely opened.
  • the proximal end receiving portion 166 is connected to the proximal end side of the intermediate deformable portion 164 and is a portion that receives the pressing force when the connector 20 of the infusion tube comes into contact with the flange portions 58 and 138 according to the first and second embodiments. Equivalent to.
  • the base end receiving portion 166 is bent by approximately 90 ° with respect to the base end side of the intermediate deformation portion 164.
  • the connection portion 165 with the intermediate deformation portion 164 is formed in a rounded corner, but its radius of curvature is smaller than that of the tip locking portion 162.
  • the base end receiving portion 166 has a pair of leg portions 166a formed in the downward direction by notching the intermediate portion in the width direction, similarly to the distal end locking portion 162. Between the pair of leg portions 166a, a wide inverted U-shaped valley portion 166b communicating with the inner cavity of the connector 20 in a state where the inner needle 16 is passed and the connector 20 is in contact with each other is formed.
  • the material constituting the plug 160 is not particularly limited, a metal material or a resin material may be applied.
  • metal materials include pseudoelastic alloys (including superelastic alloys) such as Ni-Ti alloys, shape memory alloys, stainless steel, cobalt alloys, noble metals such as gold and platinum, tungsten alloys, carbon Examples thereof include system materials.
  • the plug 160 may be made of a resin material that is harder than the hemostasis valve 24 and has a rubber property.
  • the catheter assembly 10B is configured so that the plug 160 is inserted into the plug slit 53 of the hemostasis valve 24, and the vicinity of the top portion 164a of the intermediate deformable portion 164 is the plug slit in order to configure the punctureable state. It is arranged at a position overlapping 53. In this state, the front end locking portion 162 is just hooked on the inner wall 34a of the guide portion 34. Since the plug 160 and the hemostasis valve 24 are disposed without applying an excessive force to each other, the hollow portion 22 can be satisfactorily closed. The inner needle 16 is also inserted into the inner needle slit 52.
  • the catheter assembly 10B according to the third embodiment is basically configured as described above, and the operation and effect thereof will be described below.
  • the catheter assembly 10B is also operated in the same manner as the catheter assemblies 10 and 10A according to the first and second embodiments. That is, in the puncture enabled state, in the catheter assembly 10B, the catheter 12 and the inner needle 16 are punctured by the patient under the operation of the user, and then the inner needle 16 is pulled out. When the inner needle 16 is pulled out, the plug slit 53 is reliably closed by inserting the plug 160 into the plug slit 53 of the hemostasis valve 24. For this reason, even if blood flows into the hollow portion 22, the hemostasis valve 24 can satisfactorily block blood leakage.
  • the infusion tube connector 20 is inserted into the catheter hub 14 as shown in FIG. 16A.
  • the distal end surface of the connector 20 contacts the proximal end receiving portion 166 of the plug 160 and pushes the plug 160 in the distal direction.
  • the intermediate deformation portion 164 of the plug 160 is pushed in the axial direction, and the tip locking portion 162 is hooked, so that the plate surface of the intermediate deformation portion 164 is elastically deformed downward.
  • the top portion 164a of the plug 160 is greatly displaced, and the plug slit pressed against the plate surface of the intermediate deformable portion 164. 53 greatly opens. Therefore, the infusion agent supplied from the connector 20 flows into the proximal end side hollow portion 22b through the valley portion 166b of the proximal end receiving portion 166, and further flows into the distal end side hollow portion 22a through the plug slit 53. .
  • the infusion solution is caused to flow around the flat intermediate deformation portion 164.
  • region 84 in the front end side hollow part 22a can be suppressed.
  • the infusate that has flowed into the distal end side hollow portion 22a is easily guided to the lumen 12a of the catheter 12 and flows into the blood vessel of the patient.
  • the intermediate deformable portion 164 is elastically restored. That is, the vicinity of the top portion 164a that has been displaced downward automatically returns upward, and the plug slit 53 is closed again.
  • the plug slit 53 is hermetically sealed by the intermediate deformation portion 164, and the hemostasis valve 24 and the plug 160 firmly close the hollow portion 22. Accordingly, it is possible to favorably avoid blood from leaking into the proximal end side hollow portion 22b of the hemostasis valve 24.
  • the catheter assembly 10B according to the third embodiment can achieve the same effects as those of the catheter assemblies 10, 10A according to the first and second embodiments.
  • the intermediate deformation portion 164 of the plug 160 that is always inserted into the plug slit 53 can be elastically deformed in the vertical direction perpendicular to the left-right direction of the plug slit 53, the plug is deformed along with the deformation of the intermediate deformation portion 164.
  • the slit 53 can be easily opened.
  • the base end receiving portion 166 is formed at the base end of the plug 160, the plate-shaped intermediate deformation portion 164 can be easily deformed by the pressing force from the connector 20 of the infusion tube, and the plug slit 53 is formed. Can be opened.
  • the shape of the both ends of the plug 160 is not specifically limited, For example, you may weld the flange parts 58 and 138 which concern on 1st or 2nd embodiment by welding etc.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

A catheter assembly (10) is provided with: a catheter (12); a catheter hub (14) having a hollow part (22) which communicates with the lumen (12a) of the catheter (12); and an inner needle (16) which can be inserted into the lumen (12a) and the hollow part (22). A plug (30) and a hemostasis valve (24) are provided to the hollow part (22). The hemostasis valve (24) has an inner needle slit (52) through which the inner needle (16) is inserted, and a plug slit (53) through which the plug (30) is inserted.

Description

カテーテル組立体Catheter assembly
 本発明は、例えば、患者の血管内に挿入及び留置されることにより、患者に対する輸液を可能とするカテーテル組立体に関する。 The present invention relates to a catheter assembly that enables infusion to a patient by being inserted and placed in a patient's blood vessel, for example.
 患者に輸液を行う場合には、外針(カテーテル)と、カテーテル内に貫通配置される内針と、カテーテルの基端側を保持するハブとを備えるカテーテル組立体が用いられる。輸液ラインの構築時には、カテーテル及び内針を一体的に患者の血管内に穿刺し、穿刺後に内針のみを引き抜いてカテーテルとハブを患者側に留置し、ハブと輸液チューブを接続する。 When performing infusion to a patient, a catheter assembly including an outer needle (catheter), an inner needle penetratingly disposed in the catheter, and a hub that holds the proximal end side of the catheter is used. When constructing the infusion line, the catheter and the inner needle are punctured integrally into the blood vessel of the patient, and after the puncture, only the inner needle is withdrawn, the catheter and the hub are left on the patient side, and the hub and the infusion tube are connected.
 この種のカテーテル組立体は、輸液チューブの接続性を高めるため、血液の漏出を防ぐ止血弁(弁体)と、筒状の挿通部材とをハブ内に備える(例えば、特開2002-263197号公報参照)。すなわち、輸液チューブの接続時に、輸液チューブのコネクタにより挿通部材を押し込んで止血弁のスリットを貫通させ、止血弁よりも先端側中空部と基端側中空部とを連通する。これにより、輸液チューブから供給された輸液剤は、カテーテル組立体を介して患者に流入される。 This type of catheter assembly is provided with a hemostasis valve (valve element) for preventing blood leakage and a cylindrical insertion member in the hub in order to improve the connectivity of the infusion tube (for example, JP-A-2002-263197). See the official gazette). That is, when the infusion tube is connected, the insertion member is pushed by the connector of the infusion tube to penetrate the slit of the hemostasis valve, and the distal end side hollow portion and the proximal end side hollow portion are communicated with each other than the hemostasis valve. Thereby, the infusion agent supplied from the infusion tube flows into the patient via the catheter assembly.
 ところで、輸液においては、異なる種類の輸液剤を輸液する場合等のために、カテーテル組立体に接続される輸液チューブを取り替えることがある。このためカテーテル組立体は、特開2002-263197号公報の図5~図8に示されるように、輸液チューブの取外後にハブ内に備えたコイルスプリングにより挿通部材を押し戻して止血弁のスリットが再閉塞すると好都合である。止血弁が再閉塞することで、輸液チューブの取替時に血液の漏れが抑制されるからである。 By the way, in the case of infusion, the infusion tube connected to the catheter assembly may be replaced in order to infuse different types of infusion agents. For this reason, as shown in FIGS. 5 to 8 of Japanese Patent Application Laid-Open No. 2002-263197, the catheter assembly pushes back the insertion member with a coil spring provided in the hub after the infusion tube is removed, so that the slit of the hemostasis valve is formed. It is convenient to re-occlude. This is because when the hemostasis valve is re-occluded, blood leakage is suppressed when the infusion tube is replaced.
 しかしながら、挿通部材は、輸液剤を先端側中空部に確実に流動させるため、内針に比べて太く形成される。そのためカテーテル組立体は、挿通部材を止血弁に一旦貫通させると、止血弁によるスリットの再閉塞が不充分になる可能性がある。そして、このように再閉塞が不充分であると、血液がハブの基端側から漏れて、血液による感染の可能性が高まる、他の輸液チューブの接続が難しくなる、又は血液により見栄えが悪くなる等の不都合が生じる。 However, the insertion member is formed thicker than the inner needle in order to allow the infusion agent to flow reliably into the distal end side hollow portion. Therefore, once the insertion member passes through the hemostasis valve, the catheter assembly may not sufficiently re-slit the slit by the hemostasis valve. If the re-occlusion is insufficient, blood leaks from the proximal end of the hub, increasing the possibility of infection by blood, making it difficult to connect other infusion tubes, or poorly looking due to blood. Inconveniences such as become.
 本発明は、上記の実情に鑑みてなされたものであり、簡単な構成によって、弁体のスリットを一層確実に再閉塞させ、血液の漏出を防いでチューブの取替を簡単化することができるカテーテル組立体を提供することを目的とする。 The present invention has been made in view of the above circumstances, and with a simple configuration, the slit of the valve body can be reclosed more reliably, blood leakage can be prevented, and tube replacement can be simplified. It is an object to provide a catheter assembly.
 前記の目的を達成するために、本発明に係るカテーテル組立体は、カテーテルと、前記カテーテルを保持し、前記カテーテルの孔部に連通する中空部を有するハブと、前記孔部及び前記中空部を挿通可能な内針と、前記中空部に変位自在に配置される挿通部材と、前記中空部に設けられる弁体と、を備え、前記弁体は、前記内針が挿通される内針用スリットと、前記挿通部材が挿通される挿通部材用スリットと、を別に有することを特徴とする。 In order to achieve the above object, a catheter assembly according to the present invention comprises a catheter, a hub that holds the catheter and has a hollow portion that communicates with a hole portion of the catheter, the hole portion and the hollow portion. An inner needle that can be inserted; an insertion member that is displaceably disposed in the hollow portion; and a valve body that is provided in the hollow portion. The valve body includes an inner needle slit through which the inner needle is inserted. And an insertion member slit through which the insertion member is inserted.
 上記によれば、カテーテル組立体の弁体が内針用スリットと挿通部材用スリットの2つのスリットを有することで、弁体のスリットを一層確実に再閉塞させることができる。すなわち、弁体は、挿通部材用スリットを有するので、挿通部材を容易に通して変位させることができ、挿通部材用スリットが破損することを低減することができる。また弁体は、内針の径に応じて内針用スリットを小さく形成しても内針用スリットが無理に押し広げられず、強固な閉塞状態を維持することができる。よって、カテーテル組立体は、血液の漏出を防いでチューブの取替を簡単化することができる。 According to the above, since the valve body of the catheter assembly has the two slits of the inner needle slit and the insertion member slit, the valve body slit can be reclosed more reliably. That is, since the valve body has the slit for the insertion member, the insertion member can be easily passed through and displaced, and the damage to the slit for the insertion member can be reduced. Further, even if the inner needle slit is formed to be small according to the diameter of the inner needle, the valve body is not forced to spread, and the valve body can maintain a strong closed state. Therefore, the catheter assembly can prevent the leakage of blood and simplify the replacement of the tube.
 この場合、前記挿通部材は、前記挿通部材用スリットを閉塞する閉塞部と、前記閉塞部の基端側に連なり該閉塞部に対し形状又は位相が異なることで前記スリットを開放する開放部と、を備え、前記挿通部材用スリットには、前記閉塞部又は前記開放部のいずれか一方が常に挿入されていることが好ましい。 In this case, the insertion member includes a closing portion that closes the slit for the insertion member, and an opening portion that opens to the slit due to a different shape or phase with respect to the closing portion connected to the proximal end side of the closing portion, It is preferable that either one of the closing part or the opening part is always inserted into the insertion member slit.
 このように、挿通部材用スリットに閉塞部又は開放部のいずれか一方が常に挿入されていることで、閉塞部が挿通部材用スリットに重なる位置で、弁体と閉塞部は互いに協働して中空部を効果的に閉塞する。よって、血液の漏出をより確実に防ぐことができる。また、開放部が挿通部材用スリットに重なった状態では、挿通部材用スリットを開放させて液体を容易に流動させることができる。 In this way, either one of the blocking portion or the opening portion is always inserted into the insertion member slit, so that the valve body and the blocking portion cooperate with each other at a position where the blocking portion overlaps the insertion member slit. The hollow part is effectively blocked. Therefore, blood leakage can be prevented more reliably. Further, in a state where the opening portion overlaps the insertion member slit, the insertion member slit can be opened to allow the liquid to flow easily.
 上記の構成に加えて、前記開放部の断面形状は、前記閉塞部の断面形状に略相似し、且つ前記閉塞部に対し前記挿通部材の軸心回りに位相が略90°ずれるとよい。 In addition to the configuration described above, the cross-sectional shape of the open portion may be substantially similar to the cross-sectional shape of the closed portion, and the phase may be shifted by about 90 ° around the axis of the insertion member with respect to the closed portion.
 このように、開放部の断面形状の位相が閉塞部と相対的に略90°ずれていることで、開放部を挿通部材用スリットに挿入すると所定方向に延びる挿通部材用スリットを充分に拡げることができる。よって、液体は挿通部材用スリットをより容易に通過することができる。 As described above, the phase of the cross-sectional shape of the open portion is shifted by approximately 90 ° relative to the closed portion, so that when the open portion is inserted into the insert member slit, the insert member slit extending in a predetermined direction can be sufficiently expanded. Can do. Therefore, the liquid can pass through the insertion member slit more easily.
 また、前前記開放部は、前記弁体の前記挿通部材用スリットが設けられた閉塞膜の肉厚よりも軸方向に長い流通穴を有する構成であってもよい。 The front opening may have a flow hole that is longer in the axial direction than the thickness of the blocking membrane provided with the insertion member slit of the valve body.
 このように、開放部が閉塞膜の肉厚よりも軸方向に長い流通穴を有することで、流通穴がスリットに重なる位置に配置された状態で、液体は、流通穴を介して弁体より先端側の中空部に流入することができる。 In this way, the opening portion has a flow hole that is longer in the axial direction than the thickness of the obstruction membrane, so that the liquid can be discharged from the valve body through the flow hole in a state where the flow hole is disposed at a position overlapping the slit. It can flow into the hollow portion on the tip side.
 さらに、前記閉塞部と前記開放部は、前記挿通部材用スリットの延在方向と直交する方向の厚みが同一であることが好ましい。 Furthermore, it is preferable that the closed portion and the open portion have the same thickness in the direction orthogonal to the extending direction of the insertion member slit.
 このように、閉塞部と開放部の厚みが同一であることで、挿通部材用スリットと相対的に挿通部材を変位させる際に、挿通部材の摺動抵抗を抑えてスムーズに移動させることができる。 Thus, when the thickness of the closing part and the opening part is the same, when the insertion member is displaced relative to the insertion member slit, the sliding resistance of the insertion member can be suppressed and moved smoothly. .
 或いは、前記挿通部材用スリットには、前記挿通部材が常に挿入され、前記挿通部材は、前記挿通部材用スリットの延在方向と直交する方向に弾性変形可能な変形部を有してもよい。 Alternatively, the insertion member may always be inserted into the insertion member slit, and the insertion member may have a deformable portion that is elastically deformable in a direction orthogonal to the extending direction of the insertion member slit.
 このように、挿通部材用スリットに常に挿入される挿通部材の変形部が、挿通部材用スリットの延在方向と直交する方向に弾性変形可能であることで、変形部の変形に伴い挿通部材用スリットを容易に開放することができる。 As described above, the deforming portion of the insertion member that is always inserted into the insertion member slit can be elastically deformed in a direction orthogonal to the extending direction of the insertion member slit, so that the insertion member is deformed along with the deformation of the deformation portion. The slit can be easily opened.
 また、前記変形部は、板状に形成されて軸方向に延在し、前記挿通部材の一端には、前記変形部に湾曲して連なり前記ハブに接続されたコネクタからの押圧力を受けることが可能な受部が形成されていることが好ましい。 Further, the deforming portion is formed in a plate shape and extends in the axial direction, and one end of the insertion member receives a pressing force from a connector connected to the hub in a curved manner connected to the deforming portion. It is preferable that the receiving part which can be formed is formed.
 このように、挿通部材の一端に受部が形成されていることで、コネクタからの押圧力により板状の変形部を簡単に変形させて、挿通部材用スリットを開放することができる。 Thus, since the receiving portion is formed at one end of the insertion member, the plate-shaped deformation portion can be easily deformed by the pressing force from the connector, and the insertion member slit can be opened.
 またさらに、前記内針用スリットと前記挿通部材用スリットは平行に形成され、且つ前記挿通部材用スリットの切込幅が前記内針用スリットの切込幅よりも長いことが好ましい。 Furthermore, it is preferable that the inner needle slit and the insertion member slit are formed in parallel, and the cutting width of the insertion member slit is longer than the cutting width of the inner needle slit.
 このように、挿通部材用スリットの切込幅が内針用スリットの切込幅よりも長く、また平行に形成されていることで、仮に挿通部材用スリットの開放時等に弁体に亀裂を生じさせたとしても、亀裂が内針用スリットに向かうことを抑制することができる。よって、弁体と挿通部材による閉塞を一層確実なものとすることができる。 As described above, the slit width for the insertion member slit is longer than the slit width for the inner needle slit and is formed in parallel, so that the valve body may crack when the insertion member slit is opened. Even if it is generated, it is possible to suppress the crack from going to the inner needle slit. Therefore, the obstruction | occlusion by a valve body and an insertion member can be made still more reliable.
 本発明のカテーテル組立体によれば、簡単な構成によって、弁体のスリットを一層確実に再閉塞させ、血液の漏出を防いでチューブの取替を簡単化することができる。 According to the catheter assembly of the present invention, it is possible to more easily reclose the slit of the valve body with a simple configuration, prevent blood leakage, and simplify tube replacement.
本発明の第1実施形態に係るカテーテル組立体の全体構成を示す斜視図である。It is a perspective view showing the whole catheter assembly composition concerning a 1st embodiment of the present invention. 図1のカテーテル組立体の一部を示す分解斜視図である。FIG. 2 is an exploded perspective view showing a part of the catheter assembly of FIG. 1. 図3Aは、図1のカテーテル組立体の一部を示す側面断面図であり、図3Bは、図3AのIIIB-IIIB線断面図である。3A is a side sectional view showing a part of the catheter assembly of FIG. 1, and FIG. 3B is a sectional view taken along line IIIB-IIIB of FIG. 3A. 図2の止血弁、シール部材、プラグの関係性を示す斜視図である。It is a perspective view which shows the relationship between the hemostatic valve of FIG. 2, a sealing member, and a plug. 図5Aは、図2のカテーテル組立体のプラグを示す第1斜視図であり、図5Bは、図2のカテーテル組立体のプラグを示す第2斜視図である。5A is a first perspective view showing the plug of the catheter assembly of FIG. 2, and FIG. 5B is a second perspective view showing the plug of the catheter assembly of FIG. 図1のカテーテル組立体の一部を示す平面断面図である。FIG. 2 is a plan sectional view showing a part of the catheter assembly of FIG. 1. 図7Aは、図6のカテーテル組立体に対し輸液チューブのコネクタを接続した状態を示す平面断面図であり、図7Bは、図7AのVIIB-VIIB線断面図である。7A is a plan sectional view showing a state where the connector of the infusion tube is connected to the catheter assembly of FIG. 6, and FIG. 7B is a sectional view taken along the line VIIB-VIIB in FIG. 7A. 従来のカテーテル組立体の弁機構を概略的に示す側面断面図である。It is side surface sectional drawing which shows the valve mechanism of the conventional catheter assembly roughly. 図9Aは、図7Aのカテーテル組立体から輸液チューブのコネクタを離脱した状態を示す平面断面図であり、図9Bは、図9AのIXB-IXB線断面図である。9A is a plan sectional view showing a state where the connector of the infusion tube is detached from the catheter assembly of FIG. 7A, and FIG. 9B is a sectional view taken along line IXB-IXB in FIG. 9A. 図10Aは、第2実施形態に係るカテーテル組立体の一部を示す側面断面図であり、図10Bは、図10Aのカテーテル組立体の一部を示す平面断面図である。FIG. 10A is a side sectional view showing a part of the catheter assembly according to the second embodiment, and FIG. 10B is a plan sectional view showing a part of the catheter assembly of FIG. 10A. 図11Aは、図10Aのカテーテル組立体のプラグを示す第1斜視図であり、図11Bは、図10Aのカテーテル組立体のプラグを示す第2斜視図である。11A is a first perspective view showing the plug of the catheter assembly of FIG. 10A, and FIG. 11B is a second perspective view showing the plug of the catheter assembly of FIG. 10A. 図12Aは、図10Aのカテーテル組立体に対し輸液チューブのコネクタを接続した状態を示す平面断面図であり、図12Bは、図12AのXIIB-XIIB線断面図である。12A is a plan sectional view showing a state where the connector of the infusion tube is connected to the catheter assembly of FIG. 10A, and FIG. 12B is a sectional view taken along the line XIIB-XIIB of FIG. 12A. 図13Aは、図12Aのカテーテル組立体から輸液チューブのコネクタを離脱した状態を示す平面断面図であり、図13Bは、図13AのXIIIB-XIIIB線断面図である。13A is a plan sectional view showing a state where the connector of the infusion tube is detached from the catheter assembly of FIG. 12A, and FIG. 13B is a sectional view taken along line XIIIB-XIIIB in FIG. 13A. 図14Aは、第3実施形態に係るカテーテル組立体の一部を示す側面断面図であり、図14Bは、図14AのXIVB-XIVB線断面図である。14A is a side sectional view showing a part of the catheter assembly according to the third embodiment, and FIG. 14B is a sectional view taken along line XIVB-XIVB in FIG. 14A. 図15Aは、図14Aのカテーテル組立体のプラグを示す第1斜視図であり、図15Bは、図14Aのカテーテル組立体のプラグが弾性変形した状態を示す第2斜視図である。15A is a first perspective view showing the plug of the catheter assembly of FIG. 14A, and FIG. 15B is a second perspective view showing a state where the plug of the catheter assembly of FIG. 14A is elastically deformed. 図16Aは、図14Aのカテーテル組立体に対し輸液チューブのコネクタを接続した状態を示す平面断面図であり、図16Bは、図16AのXVIB-XVIB線断面図である。16A is a plan sectional view showing a state where the connector of the infusion tube is connected to the catheter assembly of FIG. 14A, and FIG. 16B is a sectional view taken along the line XVIB-XVIB of FIG. 16A. 図17Aは、図16Aのカテーテル組立体から輸液チューブのコネクタを離脱した状態を示す平面断面図であり、図17Bは、図17AのXVIIB-XVIIB線断面図である。17A is a plan sectional view showing a state where the connector of the infusion tube is detached from the catheter assembly of FIG. 16A, and FIG. 17B is a sectional view taken along line XVIIB-XVIIB in FIG. 17A.
 以下、本発明に係るカテーテル組立体について好適な実施形態を挙げ、添付の図面を参照して詳細に説明する。 Hereinafter, preferred embodiments of the catheter assembly according to the present invention will be described and described in detail with reference to the accompanying drawings.
〔第1実施形態〕
 第1実施形態に係るカテーテル組立体10は、図1に示すように、カテーテル12(外針)と、カテーテル12の基端を接続保持するカテーテルハブ14と、カテーテル12内に貫通配置される内針16と、内針16の基端を保持する内針ハブ18とを備える。
[First Embodiment]
As shown in FIG. 1, the catheter assembly 10 according to the first embodiment includes a catheter 12 (outer needle), a catheter hub 14 that connects and holds the proximal end of the catheter 12, and an inner portion that is disposed through the catheter 12. A needle 16 and an inner needle hub 18 that holds the proximal end of the inner needle 16 are provided.
 医師や看護師等のユーザは、カテーテル組立体10の内針ハブ18を把持操作して、その先端部を患者の血管に穿刺する。カテーテル組立体10の先端部は、穿刺時に、カテーテル12と内針16が2重に重なっており(以下、穿刺可能状態ともいう)、患者の血管内に一体的に挿入される。また、穿刺可能状態では、カテーテルハブ14の基端側と内針ハブ18の先端側が接続され、内針ハブ18がカテーテルハブ14を支持している。 A user such as a doctor or nurse grasps the inner needle hub 18 of the catheter assembly 10 and punctures the distal end portion of the blood vessel of the patient. The distal end portion of the catheter assembly 10 has the catheter 12 and the inner needle 16 overlapped at the time of puncturing (hereinafter also referred to as a puncturable state), and is inserted integrally into the blood vessel of the patient. In the puncture enabled state, the proximal end side of the catheter hub 14 and the distal end side of the inner needle hub 18 are connected, and the inner needle hub 18 supports the catheter hub 14.
 患者への穿刺後、ユーザは、内針ハブ18を基端方向に引き抜く(後退移動する)ことで、カテーテルハブ14から内針ハブ18を離脱させる。これに伴い、内針ハブ18に保持されている内針16も一体的に引き抜かれ、カテーテル12及びカテーテルハブ14から離脱する。すなわち、内針16が患者の血管から抜去される。従って、患者側は、カテーテル12の先端側が血管内に挿入され、カテーテル12の基端側及びカテーテルハブ14が皮膚上に留置される。その後、カテーテルハブ14の基端側に輸液チューブのコネクタ20(図7A参照)を接続することで、輸液チューブから患者への輸液剤(薬液)の投与が実施される。以下、このカテーテル組立体10の構成について具体的に説明していく。 After puncturing the patient, the user pulls out the inner needle hub 18 in the proximal direction (retreats), thereby detaching the inner needle hub 18 from the catheter hub 14. Along with this, the inner needle 16 held by the inner needle hub 18 is also pulled out and detached from the catheter 12 and the catheter hub 14. That is, the inner needle 16 is removed from the patient's blood vessel. Therefore, on the patient side, the distal end side of the catheter 12 is inserted into the blood vessel, and the proximal end side of the catheter 12 and the catheter hub 14 are placed on the skin. Thereafter, an infusion solution (medical solution) is administered from the infusion tube to the patient by connecting the connector 20 (see FIG. 7A) of the infusion tube to the proximal end side of the catheter hub 14. Hereinafter, the configuration of the catheter assembly 10 will be specifically described.
 カテーテル12は、可撓性を有し所定長さに形成された管状の部材である。カテーテル12の内部には、軸方向に延在する内腔12aが形成されている。内腔12aは、内針16を挿通可能な内径に設定されている。 The catheter 12 is a tubular member that is flexible and has a predetermined length. A lumen 12 a extending in the axial direction is formed inside the catheter 12. The inner cavity 12a is set to an inner diameter through which the inner needle 16 can be inserted.
 カテーテル12の構成材料は、特に限定されるものではないが、樹脂材料、特に軟質樹脂材料が好適であり、例えば、ポリテトラフルオロエテレン(PTFE)、エチレン・テトラフルオロエテレン共重合体(ETFE)、ベルフルオロアルコキシフッ素樹脂(PFA)等のフッ素系樹脂、ポリエチレン、ポリプロピレン等のオレフィン系樹脂又はこれらの混合物、ポリウレタン、ポリエステル、ポリアミド、ポリエーテルナイロン樹脂、前記オレフィン系樹脂とエチレン-酢酸ビニル共重合体との混合物等が挙げられる。 The constituent material of the catheter 12 is not particularly limited, but a resin material, particularly a soft resin material, is suitable. For example, polytetrafluoroetherene (PTFE), ethylene-tetrafluoroethylene copolymer (ETFE). ), Fluorinated resins such as bellfluoroalkoxy fluororesin (PFA), olefinic resins such as polyethylene and polypropylene, or mixtures thereof, polyurethane, polyester, polyamide, polyether nylon resin, the olefinic resin and ethylene-vinyl acetate Examples thereof include a mixture with a polymer.
 また、カテーテル12は、全部又は一部の内部を視認できるように透明性を有するとよい。これにより、カテーテル12を血管内に挿入した状態で、血液がカテーテル12の内腔12aを通ってカテーテルハブ14に流入する現象(フラッシュバックとも呼ばれる)を目視で確認することができる。 Further, the catheter 12 may have transparency so that the whole or a part of the inside can be visually recognized. Accordingly, it is possible to visually confirm a phenomenon (also referred to as flashback) in which blood flows into the catheter hub 14 through the lumen 12a of the catheter 12 with the catheter 12 inserted into the blood vessel.
 カテーテル12の基端部は、例えば、かしめ、融着(熱融着、高周波融着等)、接着剤による接着等の適宜の接合方法によって、カテーテルハブ14内の先端部に固定される。第1実施形態に係るカテーテル組立体10は、図示しないかしめピンによりカテーテルハブ14の内面との間でカテーテル12を挟持している。 The proximal end portion of the catheter 12 is fixed to the distal end portion in the catheter hub 14 by an appropriate joining method such as caulking, fusion (thermal fusion, high frequency fusion, etc.), adhesion with an adhesive, or the like. The catheter assembly 10 according to the first embodiment holds the catheter 12 between the inner surface of the catheter hub 14 by a caulking pin (not shown).
 カテーテル12を保持するカテーテルハブ14は、先端方向に先細りとなる筒状に成形されている。カテーテルハブ14は、カテーテル12と輸液チューブ間に介在することで両部材を簡単且つ確実に接続(連通)させる。カテーテルハブ14の上部には、カテーテル12を血管内に押し込むための操作用突起14aが形成されている。カテーテルハブ14は、カテーテル12が血管に穿刺された状態で患者の皮膚上に露呈され、テープ等により貼り付けられて留置される。 The catheter hub 14 that holds the catheter 12 is formed in a cylindrical shape that tapers in the distal direction. The catheter hub 14 is interposed between the catheter 12 and the infusion tube so that both members can be connected (communicated) easily and reliably. An operation protrusion 14 a for pushing the catheter 12 into the blood vessel is formed on the upper portion of the catheter hub 14. The catheter hub 14 is exposed on the patient's skin in a state where the catheter 12 is punctured into a blood vessel, and is affixed with a tape or the like.
 カテーテルハブ14は、カテーテル12よりも硬い材料によって構成されることが好ましい。カテーテルハブ14の構成材料は、特に限定されるものではないが、例えば、ポリカーボネート、ポリアミド、ポリサルホン、ポリアリレート、メタクリレート-ブチレン-スチレン共重合体等の熱可塑性樹脂を好適に用いることができる。 The catheter hub 14 is preferably made of a material harder than the catheter 12. The constituent material of the catheter hub 14 is not particularly limited. For example, a thermoplastic resin such as polycarbonate, polyamide, polysulfone, polyarylate, methacrylate-butylene-styrene copolymer can be suitably used.
 カテーテルハブ14の内部には、軸方向に貫通形成され、輸液剤を流通可能な中空部22が設けられている。この中空部22は、カテーテルハブ14の基端開口部14bに連通しており、図2に示すように、止血弁24(弁体)、シール部材26、バネ28(弾性部材)、プラグ30(挿通部材)が収容される。これら各部材については後に詳述する。 The inside of the catheter hub 14 is provided with a hollow portion 22 that is formed so as to penetrate in the axial direction and through which an infusion solution can flow. The hollow portion 22 communicates with the proximal end opening 14b of the catheter hub 14, and as shown in FIG. 2, the hemostasis valve 24 (valve element), the seal member 26, the spring 28 (elastic member), the plug 30 ( Insertion member) is accommodated. Each of these members will be described in detail later.
 カテーテル組立体10の内針16は、患者の皮膚を穿刺可能な剛性を有する管状の部材に形成される。内針16の構成材料としては、例えば、ステンレス鋼、アルミニウム、アルミニウム合金、チタン又はチタン合金のような金属材料が挙げられる。内針16は、カテーテル12に比べて充分に長く形成され、穿刺可能状態においてカテーテル12の先端開口から鋭利な針先16aが突出するように構成される。内針16は、胴体部がカテーテルハブ14の中空部22を通り、胴体部に連なる基端部が内針ハブ18内の内針保持部材(図示せず)に固定保持されることで姿勢が維持される。 The inner needle 16 of the catheter assembly 10 is formed as a tubular member having rigidity capable of puncturing the patient's skin. Examples of the constituent material of the inner needle 16 include a metal material such as stainless steel, aluminum, an aluminum alloy, titanium, or a titanium alloy. The inner needle 16 is formed to be sufficiently longer than the catheter 12, and is configured such that a sharp needle tip 16a protrudes from the distal end opening of the catheter 12 in a puncturable state. The posture of the inner needle 16 is such that the body portion passes through the hollow portion 22 of the catheter hub 14 and the proximal end portion connected to the body portion is fixed and held by an inner needle holding member (not shown) in the inner needle hub 18. Maintained.
 なお、図2中では、カテーテルハブ14の基端側から内針16を挿入するように図示しているが、内針16の組付時には、内針ハブ18の接続前にカテーテル12の先端開口から内針16の基端を挿入していくとよい。これにより針先16aがカテーテルハブ14や止血弁24、シール部材26に突き刺さることを回避して、内針16の組付をスムーズに行うことができる。 In FIG. 2, the inner needle 16 is inserted from the proximal end side of the catheter hub 14. However, when the inner needle 16 is assembled, the distal end of the catheter 12 is opened before the inner needle hub 18 is connected. It is preferable to insert the proximal end of the inner needle 16 from the top. Thus, the needle tip 16a can be prevented from sticking into the catheter hub 14, the hemostasis valve 24, and the seal member 26, and the inner needle 16 can be assembled smoothly.
 図1に戻り、内針16を保持する内針ハブ18は、ユーザが把持して、カテーテル12及び内針16の2重管体を安定的に操作し得る長尺な筐体に形成されている。内針ハブ18の内部には、カテーテルハブ14から内針ハブ18の離脱に伴い内針16を収容する図示しない収容機構が設けられている。 Returning to FIG. 1, the inner needle hub 18 that holds the inner needle 16 is formed in a long casing that can be gripped by the user and stably operate the double tube body of the catheter 12 and the inner needle 16. Yes. Inside the inner needle hub 18, a housing mechanism (not shown) that houses the inner needle 16 when the inner needle hub 18 is detached from the catheter hub 14 is provided.
 上記のカテーテル組立体10は、穿刺可能状態で、軸方向の先端側からカテーテル12と内針16の2重構造、カテーテルハブ14、内針ハブ18が順に接続され、一体的に取扱い可能となっている。また、カテーテル組立体10の穿刺可能状態では、図3Aに示すように、カテーテルハブ14の中空部22内にバネ28、止血弁24、シール部材26、プラグ30が適宜配置される。 In the catheter assembly 10 described above, the double structure of the catheter 12 and the inner needle 16, the catheter hub 14 and the inner needle hub 18 are sequentially connected from the distal end side in the axial direction so that they can be handled integrally. ing. When the catheter assembly 10 is puncturable, a spring 28, a hemostatic valve 24, a seal member 26, and a plug 30 are appropriately disposed in the hollow portion 22 of the catheter hub 14, as shown in FIG. 3A.
 カテーテルハブ14の中空部22は、先端側から基端側に向かってカテーテル接続部32、案内部34、弁配置部36及びコネクタ接続部38を有する。カテーテル接続部32は、カテーテルハブ14の先端部において、カテーテル12の外径に略一致する内壁32aによって構成される。カテーテル12の基端部は、このカテーテル接続部32の内壁32aとかしめピンにより強固に固着される。 The hollow portion 22 of the catheter hub 14 includes a catheter connection portion 32, a guide portion 34, a valve placement portion 36, and a connector connection portion 38 from the distal end side toward the proximal end side. The catheter connection portion 32 is configured by an inner wall 32a that substantially matches the outer diameter of the catheter 12 at the distal end portion of the catheter hub 14. The proximal end portion of the catheter 12 is firmly fixed by the inner wall 32a of the catheter connection portion 32 and a caulking pin.
 案内部34は、先端側がカテーテル接続部32に連なり、基端側から供給される輸液剤をカテーテル12の内腔12aに導くように形成される。案内部34を構成する内壁34aは、その先端側の内径が内腔12aに向かって小径となるテーパ面(漏斗状)に形成されている。 The guide portion 34 is formed so that the distal end side is connected to the catheter connecting portion 32 and the infusion agent supplied from the proximal end side is guided to the lumen 12 a of the catheter 12. The inner wall 34a constituting the guide portion 34 is formed in a tapered surface (funnel shape) in which the inner diameter on the distal end side becomes smaller toward the inner cavity 12a.
 また、案内部34にはバネ28が配置される。バネ28は、螺旋状に形成され、カテーテルハブ14の内壁34a(案内部34のテーパ面)と、後述するプラグ30に挟まれるように配置される。このバネ28は、案内部34のテーパ面に嵌込み可能な径に形成され、軸方向に所定長さ(一端が接触する内壁34aから止血弁24の手前までの長さ)を有する。バネ28は、コネクタ20が中空部22内に挿入されてプラグ30が先端方向に押し込まれることで、軸方向に縮小してプラグ30を基端方向に付勢する。従って、バネ28は、コネクタ20が中空部22内から離脱すると、全長に応じてプラグ30を基端方向に押し戻す。 Further, a spring 28 is disposed in the guide portion 34. The spring 28 is formed in a spiral shape and is disposed so as to be sandwiched between the inner wall 34a of the catheter hub 14 (the tapered surface of the guide portion 34) and a plug 30 described later. The spring 28 is formed in a diameter that can be fitted into the tapered surface of the guide portion 34, and has a predetermined length in the axial direction (the length from the inner wall 34a that contacts one end to the front of the hemostasis valve 24). The spring 28 is contracted in the axial direction when the connector 20 is inserted into the hollow portion 22 and the plug 30 is pushed in the distal direction, and biases the plug 30 in the proximal direction. Therefore, when the connector 20 is detached from the hollow portion 22, the spring 28 pushes the plug 30 back in the proximal direction according to the total length.
 一方、弁配置部36は、先端側が案内部34に連なり、案内部34の内壁34aよりも若干大径の内壁36aによって構成される。つまり案内部34と弁配置部36の間には段差が形成されている。この弁配置部36には、止血弁24及びシール部材26が配置される。 On the other hand, the valve arrangement part 36 is connected to the guide part 34 at the tip side, and is constituted by an inner wall 36a having a slightly larger diameter than the inner wall 34a of the guide part 34. That is, a step is formed between the guide portion 34 and the valve placement portion 36. The hemostatic valve 24 and the seal member 26 are arranged in the valve arrangement portion 36.
 止血弁24は、有底筒状に形成された弾性部材であり、血液の流通を遮断する機能を有する。この止血弁24は、カテーテルハブ14の中空部22を、先端側中空部22aと基端側中空部22bに分断するように配置される。止血弁24を構成する弾性材料としては、例えば、天然ゴム、イソプレンゴム、ブチルゴム、ブタジエンゴム、スチレン-ブタジエンゴム、ウレタンゴム、ニトリルゴム、アクリルゴム、フッ素ゴム、シリコーンゴムのような各種ゴム材料(特に加硫処理したもの)や、ウレタン系、ポリエステル系、ポリアミド系、オレフィン系、スチレン系等の各種熱可塑性エラストマー、或いはそれらの混合物等の各種弾性材料が挙げられる。この止血弁24については、後述するプラグ30の構成にも関わるため、後に具体的な構成を説明する。 The hemostasis valve 24 is an elastic member formed in a bottomed cylindrical shape and has a function of blocking blood circulation. The hemostasis valve 24 is disposed so as to divide the hollow portion 22 of the catheter hub 14 into a distal end side hollow portion 22a and a proximal end side hollow portion 22b. Examples of the elastic material constituting the hemostasis valve 24 include various rubber materials such as natural rubber, isoprene rubber, butyl rubber, butadiene rubber, styrene-butadiene rubber, urethane rubber, nitrile rubber, acrylic rubber, fluorine rubber, and silicone rubber ( In particular, those obtained by vulcanization), various elastomers such as urethane, polyester, polyamide, olefin, styrene, and other thermoplastic elastomers, or mixtures thereof. Since the hemostasis valve 24 is also related to the configuration of the plug 30 described later, a specific configuration will be described later.
 なお、止血弁24が固定される弁配置部36の内壁36aには、複数の内周溝部40が設けられている。内周溝部40は、先端部が案内部34と弁配置部36の間の段差部分を切り欠くようにして形成され、この先端部から弁配置部36の内壁36aに沿って軸方向に延びている。内周溝部40は、先端側中空部22aに内在する空気を、基端側中空部22bに移動させる。 A plurality of inner circumferential groove portions 40 are provided on the inner wall 36a of the valve arrangement portion 36 to which the hemostasis valve 24 is fixed. The inner circumferential groove portion 40 is formed such that the tip portion cuts out a stepped portion between the guide portion 34 and the valve placement portion 36, and extends in the axial direction along the inner wall 36 a of the valve placement portion 36 from the tip portion. Yes. The inner peripheral groove portion 40 moves the air present in the distal end side hollow portion 22a to the proximal end side hollow portion 22b.
 また、止血弁24の基端側には、シール部材26が装着される。図2に示すように、カテーテル組立体10は、止血弁24とシール部材26を相互に回転不能に嵌め込む構成となっている。具体的には、止血弁24の外周面には、複数(図2中では3つ)の嵌込み用溝24aが形成され、シール部材26には、嵌込み用溝24aに対応する複数の嵌込み用突部26aが形成されている。 Also, a seal member 26 is attached to the proximal end side of the hemostasis valve 24. As shown in FIG. 2, the catheter assembly 10 has a configuration in which the hemostasis valve 24 and the seal member 26 are fitted to each other so as not to rotate. Specifically, a plurality (three in FIG. 2) of fitting grooves 24a are formed on the outer peripheral surface of the hemostasis valve 24, and a plurality of fittings corresponding to the fitting grooves 24a are formed on the seal member 26. A protrusion 26a for insertion is formed.
 シール部材26は、この嵌込み用突部26aと、嵌込み用突部26aの基端側で弁配置部36の内径に一致する基端筒部44と、基端筒部44を軸方向に貫通する貫通孔46とを有する。基端筒部44は、内周溝部40を塞いで弁配置部36の内壁36aに密着するように配置される。これにより、止血弁24とシール部材26は、カテーテルハブ14内に強固に固定される。 The seal member 26 includes an insertion protrusion 26a, a proximal end tubular portion 44 that matches the inner diameter of the valve placement portion 36 on the proximal end side of the insertion protrusion 26a, and the proximal end tubular portion 44 in the axial direction. And a through hole 46 therethrough. The proximal end cylinder portion 44 is disposed so as to close the inner circumferential groove portion 40 and to be in close contact with the inner wall 36 a of the valve placement portion 36. Thereby, the hemostasis valve 24 and the seal member 26 are firmly fixed in the catheter hub 14.
 シール部材26は、気体を通過させ、且つ液体を通過させない材料によって構成されている。シール部材26を構成する材料としては、例えば、ポリエチレン製の焼結体等の多孔質体で形成したものを好適に用いることができる。つまり、シール部材26は、内周溝部40を移動してきた空気を基端方向に抜けさせる一方で、内周溝部40を移動してきた血液を遮断する。 The seal member 26 is made of a material that allows gas to pass but does not allow liquid to pass. As a material constituting the seal member 26, for example, a material formed of a porous body such as a polyethylene sintered body can be suitably used. That is, the seal member 26 blocks the blood that has moved through the inner circumferential groove 40 while allowing the air that has moved through the inner circumferential groove 40 to escape in the proximal direction.
 図3Aに示すように、カテーテルハブ14のコネクタ接続部38は、先端側が弁配置部36に連なると共に、カテーテルハブ14の基端開口部14bまで延在している。コネクタ接続部38は、輸液チューブのコネクタ20を嵌め込み(挿入接続)可能に構成されている。コネクタ接続部38の基端側の内壁38aは、コネクタ20との接続性を高めるため、先端方向に向かって僅かに小径となるテーパ状に形成されている。 As shown in FIG. 3A, the connector connecting portion 38 of the catheter hub 14 is connected to the valve placement portion 36 at the distal end side and extends to the proximal end opening portion 14b of the catheter hub 14. The connector connecting portion 38 is configured so that the connector 20 of the infusion tube can be fitted (inserted connection). The inner wall 38a on the proximal end side of the connector connecting portion 38 is formed in a tapered shape having a slightly smaller diameter toward the distal end direction in order to improve the connectivity with the connector 20.
 そして、穿刺可能状態では、弁配置部36とコネクタ接続部38内にプラグ30が変位自在に配置される。プラグ30は、止血弁24と共に、カテーテル組立体10における血液の遮断及び輸液剤の供給を可能とする弁機構として機能する。カテーテル組立体10は、この弁機構を適宜構成することにより輸液剤の流動性の向上や輸液チューブの取替の容易化を図っている。以下、第1実施形態に係る止血弁24及びプラグ30の構成について、具体的に説明していく。 In the state where puncturing is possible, the plug 30 is disposed in the valve placement portion 36 and the connector connection portion 38 so as to be displaceable. The plug 30 functions together with the hemostasis valve 24 as a valve mechanism that enables blocking of blood in the catheter assembly 10 and supply of an infusion solution. The catheter assembly 10 is configured by appropriately configuring this valve mechanism to improve fluidity of the infusion solution and facilitate replacement of the infusion tube. Hereinafter, the configuration of the hemostasis valve 24 and the plug 30 according to the first embodiment will be specifically described.
 図4に示すように、有底筒状に形成される止血弁24は、弁配置部36の内壁36aに密着固定される側周部48と、側周部48の先端側に連なって底部を構成する閉塞膜50とを含む。止血弁24の閉塞膜50は、側周部48よりも厚肉に形成されており弾性変形が容易である。閉塞膜50には、内針16を通すための内針用スリット52と、プラグ30を通すためのプラグ用スリット53とが形成されている。 As shown in FIG. 4, the hemostasis valve 24 formed in a bottomed cylindrical shape includes a side peripheral portion 48 that is tightly fixed to the inner wall 36 a of the valve placement portion 36, and a bottom portion that continues to the distal end side of the side peripheral portion 48. And the occluding film 50 to be configured. The occlusion film 50 of the hemostasis valve 24 is formed thicker than the side peripheral portion 48 and is easily elastically deformed. An inner needle slit 52 for passing the inner needle 16 and a plug slit 53 for passing the plug 30 are formed in the closing film 50.
 内針用スリット52は、閉塞膜50の中心部に位置し、止血弁24からの内針16の引き抜きに伴い簡単に閉塞する充分に短い切込幅に形成されている。また、内針用スリット52は、1本の線状で閉塞膜50の厚み方向に貫通形成され、止血弁24の弾性力により自己閉塞する。 The inner needle slit 52 is located at the center of the occlusion membrane 50 and is formed with a sufficiently short cutting width that easily closes as the inner needle 16 is pulled out of the hemostasis valve 24. In addition, the inner needle slit 52 is formed in a single line so as to penetrate in the thickness direction of the occlusion film 50 and is self-occluded by the elastic force of the hemostasis valve 24.
 プラグ用スリット53も、内針用スリット52と同様に、閉塞膜50の厚み方向に貫通形成されている。このプラグ用スリット53は、閉塞膜50の中心(内針用スリット52)に対しずれる位置で、内針用スリット52の切込方向(左右方向)と平行になるように設けられる。例えば図示例に示すように、プラグ用スリット53は、内針用スリット52の上方向に所定間隔離間し、内針用スリット52よりも長い切込幅に形成されている。 Similarly to the inner needle slit 52, the plug slit 53 is also formed penetrating in the thickness direction of the blocking film 50. The plug slit 53 is provided so as to be parallel to the cutting direction (left-right direction) of the inner needle slit 52 at a position shifted from the center of the blocking film 50 (inner needle slit 52). For example, as shown in the illustrated example, the plug slits 53 are spaced apart from each other by a predetermined distance in the upward direction of the inner needle slit 52 and are formed to have a longer cut width than the inner needle slit 52.
 なお、カテーテル組立体10は、後述するように止血弁24に対しプラグ30が常に挿入状態となる。よって、プラグ用スリット53は、プラグ30と協働して閉塞膜50を密閉できれば、その切込形状について特に限定されるものではない。例えば、プラグ用スリット53は、プラグ30が挿入されていない状態で開口していてもよい。 In the catheter assembly 10, the plug 30 is always inserted into the hemostasis valve 24 as described later. Therefore, the slit 53 for plugs is not particularly limited in terms of the cut shape as long as the closing film 50 can be sealed in cooperation with the plug 30. For example, the plug slit 53 may be opened in a state where the plug 30 is not inserted.
 また、内針用スリット52やプラグ用スリット53を構成する止血弁24の内面には、内針16やプラグ30の摺動を良好にする潤滑剤が塗布されていてもよい。さらに、止血弁24は、プラグ30が挿入されてもプラグ用スリット53が破れないように破損防止手段(例えば、スリットの周縁部を柔軟にする等)が設けられていてもよい。 Further, a lubricant that makes sliding of the inner needle 16 and the plug 30 good may be applied to the inner surface of the hemostasis valve 24 constituting the inner needle slit 52 and the plug slit 53. Further, the hemostasis valve 24 may be provided with breakage prevention means (for example, making the peripheral edge of the slit flexible, etc.) so that the plug slit 53 is not broken even when the plug 30 is inserted.
 プラグ30は、上述したように、輸液チューブのコネクタ20に押し出されて止血弁24のプラグ用スリット53を貫通することで、輸液チューブから供給される輸液剤を先端側中空部22aに流動させる。このため、プラグ30は、止血弁24を貫通した状態で、カテーテルハブ14の案内部34、弁配置部36、コネクタ接続部38にわたって存在し得る長さに形成されている(図3A参照)。 As described above, the plug 30 is pushed out by the connector 20 of the infusion tube and passes through the plug slit 53 of the hemostasis valve 24, thereby causing the infusion agent supplied from the infusion tube to flow into the distal end side hollow portion 22a. For this reason, the plug 30 is formed in a length that can exist over the guide portion 34, the valve placement portion 36, and the connector connection portion 38 of the catheter hub 14 in a state of penetrating the hemostasis valve 24 (see FIG. 3A).
 図5A及び図5Bに示すように、プラグ30は、先端側から基端側に向かって順に、閉塞頭部54(閉塞部)、開放胴部56(開放部)及びフランジ部58を有する。閉塞頭部54と開放胴部56は、フランジ部58の中心を通るプラグ30の軸心に対し径方向外側にずれ、且つ相互の位相が軸心周りに90°ずれる位置に設けられている。 As shown in FIGS. 5A and 5B, the plug 30 has a closed head portion 54 (closed portion), an open body portion 56 (open portion), and a flange portion 58 in this order from the distal end side toward the proximal end side. The closed head portion 54 and the open body portion 56 are provided at positions that are shifted radially outward with respect to the axial center of the plug 30 that passes through the center of the flange portion 58 and that their phases are shifted by 90 ° around the axial center.
 閉塞頭部54は、止血弁24のプラグ用スリット53の挿入状態でプラグ用スリット53を閉塞する、すなわち止血弁24と協働して中空部22を前後に遮断することが可能である。この閉塞頭部54は、断面視(図3B参照)で略半円形状を呈し、側面断面視(図3A参照)で閉塞膜50の膜厚よりも多少長い軸方向長さに形成されている。閉塞頭部54の断面積は、プラグ用スリット53に応じて適宜設定されればよいが、閉塞膜50が破れない程度にプラグ用スリット53を上下に押し広げることが可能な肉厚を有するとよい。 The occlusion head 54 closes the plug slit 53 in the inserted state of the plug slit 53 of the hemostasis valve 24, that is, it can block the hollow portion 22 back and forth in cooperation with the hemostasis valve 24. The closed head 54 has a substantially semicircular shape in a cross-sectional view (see FIG. 3B), and is formed in an axial length slightly longer than the film thickness of the occluded film 50 in a side cross-sectional view (see FIG. 3A). . The cross-sectional area of the blocking head 54 may be set as appropriate according to the plug slit 53, but has a thickness that can push the plug slit 53 up and down to the extent that the blocking film 50 is not broken. Good.
 図5A及び図5Bに示すように、閉塞頭部54の先端部には、閉塞頭部54の側周面から外側に突出する抜止め部54aが設けられている。抜止め部54aは、プラグ用スリット53の口縁に引っ掛かることで、プラグ30が基端方向に抜けることを阻止する。また、閉塞頭部54の先端面は、抜止め部54aにより面積が大きくなると共に平坦状に形成されており、バネ28の一端を受ける座として機能する。なお、抜止め部54aの構成は、特に限定されるものではなく、例えば閉塞頭部54の表面にプラグ用スリット53の口縁が入り込み可能な溝部を形成してもよく、閉塞頭部54自体の断面積を充分に大きくすることでも同様の効果が得られる。 As shown in FIGS. 5A and 5B, the distal end portion of the closed head portion 54 is provided with a retaining portion 54 a that protrudes outward from the side peripheral surface of the closed head portion 54. The retaining portion 54 a is prevented from being pulled out in the proximal direction by being caught by the mouth edge of the plug slit 53. In addition, the front end surface of the closed head 54 has a large area and is formed flat by the retaining portion 54 a, and functions as a seat for receiving one end of the spring 28. The configuration of the retaining portion 54a is not particularly limited. For example, a groove portion into which the lip of the plug slit 53 can enter can be formed on the surface of the closed head portion 54, or the closed head portion 54 itself. The same effect can be obtained by sufficiently increasing the cross-sectional area.
 開放胴部56は、閉塞頭部54の基端側に連なる連結部64と、連結部64の基端側に連なりフランジ部58まで延びる延在部66とを有する。連結部64は、開放胴部56(延在部66)と軸心回りに位相が90°ずれる閉塞頭部54に向かって滑らかに連続する部位である。具体的に、連結部64の下部側の側辺は、延在部66から先端側に向かって上方向に傾斜し、連結部64の軸心を臨む側の側辺は、延在部66から先端側に向かって幅方向に傾斜することで、閉塞頭部54を支持している。 The open body portion 56 includes a connecting portion 64 that is continuous to the proximal end side of the closed head portion 54 and an extending portion 66 that is continuous to the proximal end side of the connecting portion 64 and extends to the flange portion 58. The connecting portion 64 is a portion that smoothly continues toward the closed head portion 54 whose phase is shifted by 90 ° around the axial center with respect to the open body portion 56 (extending portion 66). Specifically, the lower side of the connecting portion 64 is inclined upward from the extending portion 66 toward the distal end side, and the side on the side facing the axial center of the connecting portion 64 is extended from the extending portion 66. The closed head 54 is supported by inclining in the width direction toward the distal end side.
 延在部66は、断面視で、閉塞頭部54と略相似する半円形状に形成され、その軸方向長さが連結部64よりも充分に長く形成されている。延在部66は、プラグ30の軸心と平行に延びて閉塞頭部54を支持し、プラグ30が先端方向に押し込まれた際に、プラグ用スリット53の延在方向に直交する方向(上下方向)にプラグ用スリット53を開口させる。 The extending portion 66 is formed in a semicircular shape that is substantially similar to the closed head portion 54 in a cross-sectional view, and its axial length is sufficiently longer than the connecting portion 64. The extending portion 66 extends in parallel with the axial center of the plug 30 to support the closed head 54, and when the plug 30 is pushed in the distal end direction, the direction (vertical direction) is perpendicular to the extending direction of the plug slit 53. The plug slit 53 is opened in the direction).
 一方、フランジ部58は、開放胴部56の基端側面から径方向外側に突出する円盤状に形成されている。このフランジ部58は、所定の板厚を有する板部68と、板部68の周縁で基端方向に多少する突出縁部70とを有する。板部68の中心部には、所定の径に形成され輸液剤を流通するための流通孔72が設けられている。開放胴部56は、板部68の先端面で流通孔72に隣接する位置に連結されている。 On the other hand, the flange portion 58 is formed in a disc shape that protrudes radially outward from the proximal side surface of the open body portion 56. The flange portion 58 includes a plate portion 68 having a predetermined plate thickness, and a protruding edge portion 70 slightly extending in the proximal direction at the periphery of the plate portion 68. At the center of the plate portion 68, there is provided a flow hole 72 that is formed to have a predetermined diameter and that circulates the infusion agent. The open body portion 56 is connected to a position adjacent to the flow hole 72 on the front end surface of the plate portion 68.
 また、突出縁部70の基端面は、輸液チューブのコネクタ20の先端面を受ける受部となっている。さらに、フランジ部58には、板部68と突出縁部70にわたって一対の孔部74が形成されている。一対の孔部74は略矩形状に形成され、開放胴部56を挟んで対向する位置に設けられている。この孔部74は、輸液剤の流通時に、基端側中空部22bに輸液剤を流入させ、基端側中空部22b内の空気を抜くように作用する。 Also, the proximal end surface of the protruding edge 70 is a receiving portion that receives the distal end surface of the connector 20 of the infusion tube. Furthermore, a pair of hole portions 74 are formed in the flange portion 58 across the plate portion 68 and the protruding edge portion 70. The pair of holes 74 are formed in a substantially rectangular shape, and are provided at positions facing each other with the open body 56 interposed therebetween. The hole 74 acts to allow the infusion agent to flow into the proximal end side hollow portion 22b and to evacuate the air in the proximal end side hollow portion 22b during circulation of the infusate.
 以上のように構成されるプラグ30は、コネクタ20からの押し込み力を受けて止血弁24のプラグ用スリット53を貫通するように比較的硬質な樹脂材料により形成されることが好ましい。プラグ30の構成材料は、特に限定されるものではないが、例えば、カテーテルハブ14の構成材料で挙げたものを適用し得る。また、プラグ30の外周面には、止血弁24に対するプラグ30の摺動性を高めるために、潤滑剤が塗布されていてもよい。 The plug 30 configured as described above is preferably formed of a relatively hard resin material so as to pass through the plug slit 53 of the hemostasis valve 24 by receiving the pushing force from the connector 20. Although the constituent material of the plug 30 is not specifically limited, For example, what was mentioned by the constituent material of the catheter hub 14 is applicable. Further, a lubricant may be applied to the outer peripheral surface of the plug 30 in order to improve the slidability of the plug 30 with respect to the hemostasis valve 24.
 さらに、第1実施形態に係るカテーテル組立体10は、シール部材26の貫通孔46によってプラグ30の回転を規制する構成となっている。図4に示すように、貫通孔46は、内針16を通すための中央孔部76と、中央孔部76に連なりプラグ30の閉塞頭部54及び開放胴部56の断面形状に一致するように切り欠かれた周辺孔部78とにより構成される。すなわち、周辺孔部78は、正面視で、2つの半円形状(第1半円部78aと第2半円部78b)が周方向に90°ずれて一部で重なるように形成されている。 Furthermore, the catheter assembly 10 according to the first embodiment is configured to restrict the rotation of the plug 30 by the through hole 46 of the seal member 26. As shown in FIG. 4, the through-hole 46 is connected to the central hole 76 for passing the inner needle 16 and the cross-sectional shape of the closed head 54 and the open body 56 of the plug 30 connected to the central hole 76. And a peripheral hole 78 cut out. That is, the peripheral hole portion 78 is formed such that two semicircular shapes (the first semicircular portion 78a and the second semicircular portion 78b) are shifted by 90 ° in the circumferential direction and partially overlap when viewed from the front. .
 カテーテル組立体10の組付け時には、第1半円部78aに閉塞頭部54が相対し、第2半円部78bに開放胴部56が相対するようにプラグ30を周方向に傾けることで、プラグ30をシール部材26に容易に通すことができる。そして、カテーテル組立体10の使用可能状態においては、プラグ30の延在部66が第1半円部78aに配置される。そのため、プラグ30は、コネクタ20の挿入に伴い先端方向に押し込まれて延在部66がプラグ用スリット53からの応力を受けたとしても、図4中の反時計回りに回転することが規制される。 When the catheter assembly 10 is assembled, the plug 30 is inclined in the circumferential direction so that the closed head portion 54 is opposed to the first semicircular portion 78a and the open body portion 56 is opposed to the second semicircular portion 78b. The plug 30 can be easily passed through the seal member 26. In the usable state of the catheter assembly 10, the extension portion 66 of the plug 30 is disposed in the first semicircular portion 78 a. Therefore, even if the plug 30 is pushed in the distal direction as the connector 20 is inserted and the extension 66 receives stress from the plug slit 53, the plug 30 is restricted from rotating counterclockwise in FIG. The
 図3A、図3B及び図6に示すように、カテーテル組立体10は、穿刺可能状態を構成するために、以上の部材を適宜組み付けてカテーテルハブ14内に収容する。この場合、止血弁24の嵌込み用溝24aにシール部材26の嵌込み用突部26aを挿入して止血弁24とシール部材26を一体化し、中空部22に先に収容したバネ28の基端側に配置する。さらに、止血弁24の閉塞膜50を貫通するようにプラグ30及び内針16を収容する。 As shown in FIGS. 3A, 3B, and 6, the catheter assembly 10 accommodates the above-mentioned members in the catheter hub 14 by appropriately assembling the above members in order to configure a punctureable state. In this case, the insertion protrusion 26 a of the seal member 26 is inserted into the insertion groove 24 a of the hemostasis valve 24 to integrate the hemostasis valve 24 and the seal member 26, and the base of the spring 28 previously accommodated in the hollow portion 22. Place on the end side. Further, the plug 30 and the inner needle 16 are accommodated so as to penetrate the occlusion membrane 50 of the hemostasis valve 24.
 すなわち、プラグ用スリット53にプラグ30を挿入し、閉塞頭部54によりプラグ用スリット53を塞いだ状態とする。この状態では、閉塞頭部54の先端面が伸長状態のバネ28に接触すると共に、延在部66がシール部材26の貫通孔46(第1半円部78a)に収容される。 That is, the plug 30 is inserted into the plug slit 53 and the plug slit 53 is closed by the closing head 54. In this state, the distal end surface of the closed head 54 comes into contact with the extended spring 28, and the extending portion 66 is accommodated in the through hole 46 (first semicircular portion 78 a) of the seal member 26.
 また、内針用スリット52にも内針16が挿通されるが、閉塞頭部54の挿入状態で閉塞膜50が下方向に押圧されるため、内針用スリット52が隙間なく閉塞される。内針16は、カテーテル12と2重管体を構成すると共に、カテーテルハブ14内を直線状に(開放胴部56と平行に)延びて流通孔72を貫通する。そして、内針ハブ18内の内針保持部材に強固に保持される。 The inner needle 16 is also inserted into the inner needle slit 52, but the inner needle slit 52 is closed without a gap because the closing film 50 is pressed downward with the closing head 54 inserted. The inner needle 16 constitutes a double tube with the catheter 12, and extends straight through the catheter hub 14 (parallel to the open body 56) and penetrates the flow hole 72. Then, it is firmly held by the inner needle holding member in the inner needle hub 18.
 第1実施形態に係るカテーテル組立体10は、基本的には以上のように構成されるものであり、以下、その作用効果について説明する。 The catheter assembly 10 according to the first embodiment is basically configured as described above, and the operation and effect thereof will be described below.
 患者に輸液を行う場合、ユーザ(医師又は看護師等)は、上記の穿刺可能状態のカテーテル組立体10を用意する。ユーザは、このカテーテル組立体10の内針ハブ18を操作して、カテーテル12及び内針16を患者の血管内に穿刺する。穿刺後は、カテーテル12及びカテーテルハブ14から内針16及び内針ハブ18を引き抜く。内針16の外径は充分に小さく、止血弁24の内針用スリット52から内針16が引き抜かれることで内針用スリット52が弾性的に閉塞する。内針16の引き抜きに伴い、患者の血液がカテーテル12の内腔12aを介して先端側中空部22aに流入する。この際、先端側中空部22aに存在していた空気は血液の流入により基端側に押し出され、内周溝部40を通って基端方向に移動し、さらにシール部材26を介してカテーテルハブ14の基端開口部14bから排出される。一方、血液は、止血弁24及びシール部材26により基端方向への漏出が遮断され、先端側中空部22aに貯留される。 When performing infusion to a patient, a user (doctor or nurse or the like) prepares the catheter assembly 10 in the above-described puncturable state. The user operates the inner needle hub 18 of the catheter assembly 10 to puncture the catheter 12 and the inner needle 16 into the blood vessel of the patient. After puncturing, the inner needle 16 and the inner needle hub 18 are pulled out from the catheter 12 and the catheter hub 14. The outer diameter of the inner needle 16 is sufficiently small, and the inner needle slit 52 is elastically closed when the inner needle 16 is pulled out from the inner needle slit 52 of the hemostasis valve 24. As the inner needle 16 is pulled out, the patient's blood flows into the distal end side hollow portion 22a through the lumen 12a of the catheter 12. At this time, the air present in the distal end side hollow portion 22a is pushed out to the proximal end side by the inflow of blood, moves in the proximal end direction through the inner peripheral groove portion 40, and further passes through the seal member 26 to the catheter hub 14. From the base end opening 14b. On the other hand, the blood is blocked from leaking in the proximal direction by the hemostasis valve 24 and the seal member 26 and stored in the distal end side hollow portion 22a.
 次に、内針16及び内針ハブ18の引き抜きにより患者の皮膚上に残ったカテーテルハブ14に対し、図7A及び図7Bに示すように、輸液チューブのコネクタ20を挿入する。コネクタ20の先端部は、カテーテルハブ14のコネクタ接続部38の内壁38aに沿うテーパ状の円筒に形成されており、中空部22にコネクタ20を所定量挿入すると、カテーテルハブ14とコネクタ20が嵌合する。 Next, as shown in FIGS. 7A and 7B, an infusion tube connector 20 is inserted into the catheter hub 14 remaining on the patient's skin by pulling out the inner needle 16 and the inner needle hub 18. The distal end portion of the connector 20 is formed into a tapered cylinder along the inner wall 38a of the connector connecting portion 38 of the catheter hub 14, and when the predetermined amount of the connector 20 is inserted into the hollow portion 22, the catheter hub 14 and the connector 20 are fitted. Match.
 コネクタ20の挿入時には、コネクタ20の先端面がプラグ30のフランジ部58に接触してプラグ30を先端方向に押し出す。カテーテルハブ14(案内部34)の内壁34aと閉塞頭部54の先端面の間に存在するバネ28は、プラグ30に押されて縮小していく。 When the connector 20 is inserted, the tip surface of the connector 20 contacts the flange portion 58 of the plug 30 to push the plug 30 in the tip direction. The spring 28 existing between the inner wall 34a of the catheter hub 14 (guide part 34) and the distal end surface of the closed head 54 is pushed by the plug 30 and contracts.
 また、先端方向に押し出されたプラグ30は、閉塞頭部54の基端側にある連結部64をプラグ用スリット53内に挿入させて、連結部64の辺部の形状に沿ってプラグ用スリット53を上下方向に開口させていく。すなわち、図3B中において、左右方向に延びるプラグ用スリット53に対し、左右方向に長く上下方向に短い断面半円形状を有する閉塞頭部54が押し出される。そして、徐々に左右方向に短く変化すると共に徐々に上下方向に長く変化する連結部64がプラグ用スリット53に挿入される。プラグ30は、シール部材26に形成された貫通孔46の形状により、図7B中の反時計回りの回転が規制されるので、良好に軸方向に移動することができる。 In addition, the plug 30 pushed in the distal direction is inserted into the slit 53 for the plug by inserting the connecting portion 64 on the proximal end side of the closed head 54 into the slit 53 for the plug along the shape of the side portion of the connecting portion 64. 53 is opened in the vertical direction. That is, in FIG. 3B, the closed head 54 having a semicircular cross section that is long in the left-right direction and short in the up-down direction is pushed out to the plug slit 53 extending in the left-right direction. Then, the connecting portion 64 that gradually changes in the left-right direction and gradually changes in the up-down direction is inserted into the plug slit 53. Since the plug 30 is restricted from rotating counterclockwise in FIG. 7B by the shape of the through hole 46 formed in the seal member 26, the plug 30 can move in the axial direction satisfactorily.
 さらに、コネクタ20を押し込んでプラグ30を挿入していくと、図7Bに示すように、閉塞頭部54と90°位相がずれた断面半円形状の延在部66がプラグ用スリット53に挿入される。これにより、左右方向に線状に形成されていたプラグ用スリット53は、左右方向に短く上下方向に長くなるように押し広げられることになり、比較的大きな流路断面積で開放する。その結果、輸液チューブから供給された輸液剤がプラグ用スリット53を容易に通過するようになる。 Further, when the connector 30 is pushed in and the plug 30 is inserted, as shown in FIG. 7B, the semicircular extension 66 having a 90 ° phase shift from the closed head 54 is inserted into the plug slit 53. Is done. As a result, the plug slit 53 formed linearly in the left-right direction is expanded so as to be short in the left-right direction and long in the up-down direction, and is opened with a relatively large channel cross-sectional area. As a result, the infusion agent supplied from the infusion tube easily passes through the plug slit 53.
 ここで、従来の弁機構(止血弁80及びプラグ82)について図8を参照して説明する。従来の弁機構は、プラグ82の先端が筒状に形成されている。このため、プラグ82は、止血弁80の貫通状態で、その周囲に液体(血液や輸液剤)が滞留し易い領域(滞留領域84)を形成することになる。プラグ30から流出した輸液剤は、この滞留領域84に殆ど回り込むことなく先端方向に移動していき、滞留領域84に流れた輸液剤や血液は停滞及び残留していた。 Here, a conventional valve mechanism (the hemostasis valve 80 and the plug 82) will be described with reference to FIG. In the conventional valve mechanism, the tip of the plug 82 is formed in a cylindrical shape. For this reason, the plug 82 forms a region (retention region 84) in which liquid (blood or infusion) is likely to stay around the hemostasis valve 80 in a penetrating state. The infusate that flowed out from the plug 30 moved in the distal direction almost without going around the stay region 84, and the infusate and blood that flowed into the stay region 84 were stagnant and remained.
 これに対し、図7A及び図7Bに示すように、カテーテル組立体10は、止血弁24よりも先端側に突出した部分が断面半円形状に形成されているので、先端側中空部22aにおいて輸液剤を側方に回り込ませる。その結果、案内部34内での滞留領域84の発生を抑制することができる。輸液剤は、案内部34に連続的に供給されることで、カテーテル12の内腔12aに容易に導かれて、患者の血管内に流入する。 On the other hand, as shown in FIGS. 7A and 7B, the catheter assembly 10 has a semicircular cross section formed at the distal end side of the hemostasis valve 24. Allow the agent to wrap around to the side. As a result, it is possible to suppress the occurrence of the stay region 84 in the guide portion 34. The infusion agent is continuously supplied to the guide portion 34, so that it is easily guided to the lumen 12a of the catheter 12 and flows into the blood vessel of the patient.
 また輸液においては、既述したように、患者の状態等に応じて輸液剤の交換等によりカテーテルハブ14からコネクタ20を取り外すことがある。この場合、ユーザは、カテーテルハブ14と相対的にコネクタ20を後退移動して、輸液チューブを引き抜く。カテーテル組立体10は、このコネクタ20の後退移動に伴い、図9A及び図9Bに示すように、プラグ30を自動的に基端方向に押し戻す構成となっている。 Also, as described above, in the infusion, the connector 20 may be detached from the catheter hub 14 by exchanging the infusion agent or the like according to the patient's condition or the like. In this case, the user retracts the connector 20 relative to the catheter hub 14 and pulls out the infusion tube. The catheter assembly 10 is configured to automatically push back the plug 30 in the proximal direction as shown in FIGS. 9A and 9B as the connector 20 moves backward.
 すなわち、コネクタ20が後退移動すると、プラグ30の前進により圧縮されていたバネ28が弾性復帰して、プラグ30を基端方向に押し出す。これにより、開放胴部56の延在部66がプラグ用スリット53から抜け、さらに連結部64もプラグ用スリット53から抜けるように作用する。連結部64はテーパ形状になっているため、比較的容易に抜ける。 That is, when the connector 20 moves backward, the spring 28 compressed by the advancement of the plug 30 is elastically restored and pushes the plug 30 in the proximal direction. Accordingly, the extending portion 66 of the open body portion 56 is detached from the plug slit 53, and the connecting portion 64 is also detached from the plug slit 53. Since the connecting portion 64 is tapered, it can be removed relatively easily.
 そして、バネ28が伸長し終わった段階では、プラグ30の閉塞頭部54がプラグ用スリット53内に位置した状態となる。この際、抜止め部54aが閉塞膜50に引っ掛かることで閉塞頭部54の抜けが抑制される。これにより、プラグ用スリット53が閉塞頭部54により隙間なく押し広げられ、止血弁24は確実に閉塞されることになる。例えば、プラグ30の挿入により閉塞膜50に破れが生じても、閉塞膜50は、閉塞頭部54の押し広げにより破れ部分が閉じられる。従って、止血弁24の基端側中空部22bに血液が漏れることを良好に回避することができる。 Then, at the stage where the spring 28 has been extended, the closed head 54 of the plug 30 is positioned in the plug slit 53. At this time, the retaining portion 54 a is caught by the obstruction film 50, so that the occlusion head 54 is prevented from coming off. As a result, the plug slit 53 is pushed and widened by the closing head 54 without a gap, and the hemostasis valve 24 is reliably closed. For example, even if the obstruction film 50 is torn due to the insertion of the plug 30, the obstruction film 50 is closed by the spread of the obstruction head 54. Accordingly, it is possible to favorably avoid blood from leaking into the proximal end side hollow portion 22b of the hemostasis valve 24.
 以上のように、第1実施形態に係るカテーテル組立体10によれば、止血弁24が内針用スリット52とプラグ用スリット53の2つのスリットを有することで、止血弁24の各スリットを一層確実に再閉塞させることができる。すなわち、止血弁24は、プラグ用スリット53を有するので、プラグ30を容易に通して変位させることができ、プラグ用スリット53が破損することを低減する。また、内針16の径に応じて内針用スリット52を小さく形成しても内針用スリット52が無理に押し広げられず、止血弁24は強固な閉塞状態を維持することができる。よって、カテーテル組立体10は、血液の漏出を防いで輸液チューブの取替を簡単化することができる。 As described above, according to the catheter assembly 10 according to the first embodiment, the hemostasis valve 24 has the two slits of the inner needle slit 52 and the plug slit 53, so that each slit of the hemostasis valve 24 is further layered. Re-occlusion can be ensured. That is, since the hemostasis valve 24 has the plug slit 53, the plug 30 can be easily passed through and displaced, thereby reducing the damage of the plug slit 53. Further, even if the inner needle slit 52 is formed to be small according to the diameter of the inner needle 16, the inner needle slit 52 is not forcibly expanded and the hemostasis valve 24 can maintain a strong closed state. Therefore, the catheter assembly 10 can prevent blood leakage and simplify replacement of the infusion tube.
 この場合、プラグ用スリット53に閉塞頭部54又は開放胴部56のいずれか一方が常に挿入されていることで、閉塞頭部54がプラグ用スリット53に重なる位置で止血弁24と閉塞頭部54が協働して中空部22を効果的に閉塞する。よって、血液の漏出をより確実に防ぐことができる。また、開放胴部56がプラグ用スリット53に重なった状態では、プラグ用スリット53を開放させて液体を容易に流動させることができる。 In this case, either one of the closed head portion 54 or the open body portion 56 is always inserted into the plug slit 53, so that the hemostatic valve 24 and the closed head portion are positioned at a position where the closed head portion 54 overlaps the plug slit 53. 54 cooperate to effectively close the hollow portion 22. Therefore, blood leakage can be prevented more reliably. In the state where the open body 56 overlaps the plug slit 53, the plug slit 53 can be opened to allow the liquid to flow easily.
 また、開放胴部56の断面形状の位相が閉塞頭部54と相対的に略90°ずれていることで、開放胴部56をプラグ用スリット53に挿入すると所定方向に延びるプラグ用スリット53を充分に拡げることができる。よって、輸液剤はプラグ用スリット53をより容易に通過することができる。さらに、プラグ用スリット53の切込幅が内針用スリット52の切込幅よりも長く、また平行に形成されていることで、仮にプラグ用スリット53の開放時等に止血弁24に亀裂を生じさせたとしても、亀裂が内針用スリット52に向かうことを抑制することができる。よって、止血弁24とプラグ30による閉塞を一層確実なものとすることができる。 Further, since the phase of the cross-sectional shape of the open body portion 56 is shifted by approximately 90 ° relative to the closed head portion 54, the plug slit 53 extending in a predetermined direction when the open body portion 56 is inserted into the plug slit 53. Can be expanded sufficiently. Therefore, the infusion agent can pass through the plug slit 53 more easily. Furthermore, since the cut width of the plug slit 53 is longer than the cut width of the inner needle slit 52 and is formed in parallel, the hemostasis valve 24 is cracked when the plug slit 53 is opened. Even if it is generated, it is possible to suppress the crack from heading toward the inner needle slit 52. Therefore, the obstruction by the hemostasis valve 24 and the plug 30 can be further ensured.
 なお、本発明に係るカテーテル組立体10は、上記の第1実施形態に限定されず、種々の実施形態、変形例及び応用例をとり得ることは勿論である。例えば、カテーテル組立体10の穿刺可能状態で、プラグ30はプラグ用スリット53に挿入されておらず、止血弁24の基端側に待機した状態であってもよい。 It should be noted that the catheter assembly 10 according to the present invention is not limited to the first embodiment described above, and of course, various embodiments, modifications, and application examples can be taken. For example, in a state where the catheter assembly 10 can be punctured, the plug 30 may not be inserted into the plug slit 53 and may be in a standby state on the proximal end side of the hemostasis valve 24.
〔第2実施形態〕
 第2実施形態に係るカテーテル組立体10Aは、図10A及び図10Bに示すように、カテーテルハブ14の中空部22に配置される各部材の構成が第1実施形態に係るカテーテル組立体10と異なる。なお、以降の説明において、第1実施形態に係るカテーテル組立体10と同じ構成又は同じ機能を奏する構成については、同一の符号を付しその詳細な説明については省略する。また以下では、内針ハブ18を省略して各構成を説明するが、第1実施形態に係る内針ハブ18を適用し得ることは勿論である。
[Second Embodiment]
As shown in FIGS. 10A and 10B, the catheter assembly 10A according to the second embodiment is different from the catheter assembly 10 according to the first embodiment in the configuration of each member disposed in the hollow portion 22 of the catheter hub 14. . In the following description, the same reference numerals are given to the same configuration or the same function as the catheter assembly 10 according to the first embodiment, and the detailed description thereof is omitted. In the following, each configuration will be described with the inner needle hub 18 omitted, but of course the inner needle hub 18 according to the first embodiment can be applied.
 具体的に、カテーテル組立体10Aに組み付けられるプラグ130は、プラグ130を基端方向に押し戻すための弾性部(バネ部132)が一体成形されている。なお、プラグ130が配置される止血弁24は、第1実施形態に係る止血弁24と同一の構成を採ることができ、内針用スリット52及びプラグ用スリット53が閉塞膜50に設けられている。また、シール部材150は、第1実施形態に係るシール部材26と異なり、貫通孔152を断面円形状に形成することが可能であり、プラグ130の回転規制を行わない。すなわち、プラグ130は、基本的に止血弁24のプラグ用スリット53に挿入され続けるため、止血弁24により回転が規制される。勿論、シール部材26は、内針16やプラグ130の断面形状に対応した貫通孔を有していてもよい。 Specifically, the plug 130 assembled to the catheter assembly 10A is integrally formed with an elastic portion (spring portion 132) for pushing the plug 130 back in the proximal direction. The hemostasis valve 24 in which the plug 130 is disposed can adopt the same configuration as the hemostasis valve 24 according to the first embodiment, and the inner needle slit 52 and the plug slit 53 are provided in the closing membrane 50. Yes. Further, unlike the seal member 26 according to the first embodiment, the seal member 150 can form the through hole 152 in a circular cross section, and does not restrict the rotation of the plug 130. That is, the plug 130 is basically continuously inserted into the plug slit 53 of the hemostasis valve 24, so that the rotation is regulated by the hemostasis valve 24. Of course, the seal member 26 may have a through hole corresponding to the cross-sectional shape of the inner needle 16 or the plug 130.
 プラグ130は、第1実施形態に係るプラグ30に比べて、充分な厚みをもった状態で、カテーテルハブ14の案内部34、弁配置部36、コネクタ接続部38にわたって収容される軸方向長さを有する。詳細には、先端側から基端側に向かって順に、バネ部132、閉塞頭部134、開放胴部136及びフランジ部138が設けられている。 The plug 130 has a sufficient thickness as compared with the plug 30 according to the first embodiment, and has an axial length that is accommodated across the guide portion 34, the valve placement portion 36, and the connector connection portion 38 of the catheter hub 14. Have Specifically, a spring part 132, a closed head part 134, an open body part 136, and a flange part 138 are provided in order from the distal end side to the proximal end side.
 図11A及び図11Bに示すように、プラグ30のバネ部132は、カテーテルハブ14の軸方向に沿って複数(図示例では5つ)のリング140を連ねることで、所定の弾性力を有するように構成される。このリング140は、厚み方向に孔部140aが貫通形成され、図10Bに示す平面視で、軸方向に短軸、幅方向に長軸を有する楕円形状に形成されている。リング140は、軸方向に押圧力がかかると、長軸方向(幅方向)に応力を逃がして、弾力的に押し潰されるように作用する。個々のリング140が弾性的に押し潰されることで、バネ部132全体として軸方向に充分に短くなる。 As shown in FIGS. 11A and 11B, the spring portion 132 of the plug 30 has a predetermined elastic force by connecting a plurality of (in the illustrated example, five) rings 140 along the axial direction of the catheter hub 14. Configured. The ring 140 has a hole 140a penetratingly formed in the thickness direction, and is formed in an elliptical shape having a short axis in the axial direction and a long axis in the width direction in a plan view shown in FIG. 10B. When a pressing force is applied in the axial direction, the ring 140 acts to release the stress in the major axis direction (width direction) and to be elastically crushed. As the individual rings 140 are crushed elastically, the entire spring portion 132 is sufficiently shortened in the axial direction.
 一方、閉塞頭部134は、バネ部132の基端側に連なり、このバネ部132よりも幅広な平板状を呈している。閉塞頭部134は、側面断面視(図10A参照)で、閉塞膜50の膜厚よりも多少長い軸方向長さを有する。また、閉塞頭部134の上面には、プラグ130がプラグ用スリット53から抜けることを防止する凸部134a(抜止め部)が突出形成されている。 On the other hand, the closed head 134 is connected to the proximal end side of the spring portion 132 and has a flat plate shape wider than the spring portion 132. The occlusion head 134 has an axial length that is slightly longer than the film thickness of the occlusion membrane 50 in a side sectional view (see FIG. 10A). Further, on the upper surface of the closed head 134, a protruding portion 134 a (prevention portion) that prevents the plug 130 from coming out of the plug slit 53 is formed to protrude.
 開放胴部136は、閉塞頭部134の基端側に連なり、閉塞頭部134と同じ幅及び厚みで基端方向に延びる平板状を呈している。開放胴部136の平板面には、厚み方向に貫通する流通穴142が形成されている。この流通穴142は、開放胴部136がプラグ用スリット53に挿入された状態で、先端側中空部22aと基端側中空部22bを連通させる機能を有する。 The open body portion 136 is connected to the proximal end side of the closed head portion 134 and has a flat plate shape extending in the proximal direction with the same width and thickness as the closed head portion 134. A flow hole 142 that penetrates in the thickness direction is formed on the flat plate surface of the open body portion 136. The flow hole 142 has a function of communicating the distal end side hollow portion 22 a and the proximal end side hollow portion 22 b in a state where the open body portion 136 is inserted into the plug slit 53.
 流通穴142は、平面視で、先端側が幅広な方形状に形成され、軸方向中間部分から基端側に向かって徐々に幅狭となるテーパ状に形成されている。この流通穴142が先端側において幅広であることで、輸液剤の流通量を充分に確保することが可能となる。また、流通穴142が基端側において幅狭であることで、プラグ130の強度を増すことができる。 The flow hole 142 is formed in a wide square shape on the front end side in a plan view, and is formed in a taper shape that gradually becomes narrower from the intermediate portion in the axial direction toward the base end side. Since the circulation hole 142 is wide on the distal end side, it is possible to sufficiently secure the circulation amount of the infusion agent. Moreover, the strength of the plug 130 can be increased because the flow hole 142 is narrow on the base end side.
 フランジ部138は、開放胴部136の基端側に連なる円盤状に形成され、さらに上下を切り欠くことにより、輸液剤を開放胴部136の上下に流動させるように構成されている。また、開放胴部136は、フランジ部138の中心部に対し上方向にずれた先端面に連結され、この開放胴部136の下側部分の切欠き144は内針16を通すことが可能な深さに形成されている。これにより内針16は、切欠き144を通してプラグ130と平行に配置される。 The flange portion 138 is formed in a disk shape continuous to the proximal end side of the open body portion 136, and is configured to cause the infusion agent to flow up and down the open body portion 136 by further notching up and down. The open body 136 is connected to a front end surface that is shifted upward with respect to the center of the flange 138, and a notch 144 on the lower side of the open body 136 can pass the inner needle 16. It is formed to a depth. As a result, the inner needle 16 is arranged in parallel with the plug 130 through the notch 144.
 図10A及び図10Bに戻り、カテーテル組立体10Aは、穿刺可能状態を構成するために、プラグ130を止血弁24のプラグ用スリット53に挿入し、閉塞頭部134によりプラグ用スリット53を塞いだ状態とする。この状態では、閉塞頭部134よりも先端側のバネ部132が、カテーテルハブ14の案内部34の内壁34aにちょうど当接する。また、内針用スリット52にも内針16が挿通されるが、閉塞頭部134の挿入状態で閉塞膜50が下方向に押圧されるため、内針用スリット52が隙間なく閉塞される。 Returning to FIGS. 10A and 10B, the catheter assembly 10A inserts the plug 130 into the plug slit 53 of the hemostasis valve 24 and closes the plug slit 53 with the closing head 134 in order to configure a punctureable state. State. In this state, the spring portion 132 on the tip side of the closed head 134 just abuts against the inner wall 34 a of the guide portion 34 of the catheter hub 14. The inner needle 16 is also inserted into the inner needle slit 52, but the inner needle slit 52 is closed without a gap because the closing film 50 is pressed downward with the closing head 134 inserted.
 第2実施形態に係るカテーテル組立体10Aは、基本的には以上のように構成されるものであり、以下その作用効果について説明する。 The catheter assembly 10A according to the second embodiment is basically configured as described above, and the operation and effect thereof will be described below.
 カテーテル組立体10Aも、第1実施形態に係るカテーテル組立体10と同様の操作がなされる。すなわち、上記の穿刺可能状態で、カテーテル組立体10Aはユーザの操作下にカテーテル12及び内針16が患者に穿刺され、その後内針16が引き抜かれる。内針16の引き抜き時には、止血弁24のプラグ用スリット53にプラグ130が挿入されていることにより、プラグ用スリット53を確実に閉塞すると共に、プラグ130より下側の内針用スリット52を積極的に閉塞させる。このため、中空部22に血液が流入しても、止血弁24は血液の漏出を良好に遮断することができる。 The catheter assembly 10A is also operated in the same manner as the catheter assembly 10 according to the first embodiment. That is, in the puncture enabled state, the catheter assembly 10A is punctured by the patient with the catheter 12 and the inner needle 16 under the operation of the user, and then the inner needle 16 is withdrawn. When the inner needle 16 is pulled out, the plug 130 is inserted into the plug slit 53 of the hemostasis valve 24, so that the plug slit 53 is reliably closed and the inner needle slit 52 below the plug 130 is positively opened. Block. For this reason, even if blood flows into the hollow portion 22, the hemostasis valve 24 can satisfactorily block blood leakage.
 次に、図12Aに示すように輸液チューブのコネクタ20をカテーテルハブ14に挿入する。コネクタ20の挿入時には、コネクタ20の先端面がプラグ130のフランジ部138に接触してプラグ130を先端方向に押し出す。これによりプラグ130のバネ部132が弾性変形して軸方向に縮小し、閉塞頭部134が閉塞膜50よりも先端方向に移動する。 Next, the infusion tube connector 20 is inserted into the catheter hub 14 as shown in FIG. 12A. When the connector 20 is inserted, the front end surface of the connector 20 comes into contact with the flange portion 138 of the plug 130 and pushes the plug 130 in the front end direction. As a result, the spring portion 132 of the plug 130 is elastically deformed and contracts in the axial direction, and the closing head 134 moves in the distal direction relative to the closing membrane 50.
 そして、プラグ130は、開放胴部136の流通穴142の先端側が閉塞膜50を越える位置まで、コネクタ20により押し込まれる。この状態では、図12Bに示すように、プラグ用スリット53に流通穴142が重なり、プラグ用スリット53を開放した状態とする。ここで、プラグ130は、第1実施形態に係るプラグ30よりも厚く形成されており、プラグ用スリット53は、開放胴部136の厚みに応じて大きく開放する。コネクタ20から供給された輸液剤は、切欠き144を通って基端側中空部22bに流入し、さらに流通穴142を通してプラグ用スリット53を通ることができる。 Then, the plug 130 is pushed by the connector 20 until the tip end side of the flow hole 142 of the open body portion 136 exceeds the blocking membrane 50. In this state, as shown in FIG. 12B, the flow hole 142 overlaps the plug slit 53 and the plug slit 53 is opened. Here, the plug 130 is formed to be thicker than the plug 30 according to the first embodiment, and the plug slit 53 is largely opened according to the thickness of the opening body 136. The infusion agent supplied from the connector 20 can flow through the notch 144 into the proximal end side hollow portion 22b and further pass through the plug slit 53 through the flow hole 142.
 また、止血弁24よりも先端側では、平板状の開放胴部136の上下に輸液剤を流出させる。このため、輸液剤をプラグ130の周囲に簡単に回り込ませることができ、先端側中空部22a内での滞留領域84(図8参照)の発生を抑制することができる。先端側中空部22aに流入した輸液剤は、カテーテル12の内腔12aに容易に導かれて、患者の血管内に流入する。 In addition, on the tip side of the hemostasis valve 24, the infusion agent flows out above and below the flat open body 136. For this reason, the infusion agent can be easily wrapped around the plug 130, and the occurrence of the stay region 84 (see FIG. 8) in the distal end side hollow portion 22a can be suppressed. The infusate that has flowed into the distal end side hollow portion 22a is easily guided to the lumen 12a of the catheter 12 and flows into the blood vessel of the patient.
 さらに、輸液剤の交換等によりカテーテルハブ14からコネクタ20を後退移動すると、図13A及び図13Bに示すように、バネ部132が弾性復帰するように動作する。つまり、バネ部132がプラグ130を自動的に基端方向に押し出すことにより、開放胴部136は、プラグ用スリット53から抜ける。 Furthermore, when the connector 20 is moved backward from the catheter hub 14 by exchanging an infusion solution or the like, as shown in FIGS. 13A and 13B, the spring portion 132 operates to return elastically. That is, the spring part 132 automatically pushes the plug 130 in the proximal direction, so that the open body part 136 comes out of the plug slit 53.
 そして、バネ28が伸長し終わった段階では、閉塞頭部134がプラグ用スリット53内に位置した状態となる。すなわち、プラグ用スリット53は、閉塞頭部134により隙間なく押し広げられて密閉状態となり、止血弁24とプラグ130は中空部22を強固に閉塞する。例えば、プラグ130の挿入により閉塞膜50に破れが生じても、閉塞頭部134が押し広げたままの閉塞膜50は、破れ部分を閉じることができる。従って、止血弁24の基端側中空部22bに血液が漏れることを良好に回避することができる。 Then, when the spring 28 has been extended, the closed head 134 is positioned in the plug slit 53. In other words, the plug slit 53 is pushed open by the closing head 134 without a gap, and becomes sealed, and the hemostasis valve 24 and the plug 130 firmly close the hollow portion 22. For example, even if the obstruction film 50 is torn due to the insertion of the plug 130, the obstruction film 50 with the obstruction head 134 being pushed and expanded can close the torn part. Accordingly, it is possible to favorably avoid blood from leaking into the proximal end side hollow portion 22b of the hemostasis valve 24.
 以上のように、第2実施形態に係るカテーテル組立体10Aでも、第1実施形態に係るカテーテル組立体10と同様の効果を得ることができる。特に、カテーテル組立体10Aは、開放胴部136が閉塞膜50の肉厚よりも軸方向に長い流通穴142を有する。そのため、開放胴部136がプラグ用スリット53に挿入され流通穴142がプラグ用スリット53に重なった状態では、基端側中空部22bと先端側中空部22aが流通穴142を介して連通する。よって輸液剤は、流通穴142を介して先端側中空部22aに容易に流入することができる。なお、開放胴部136による輸液剤の流通機構は、上下に貫通する流通穴142に限定されず、例えば開放胴部136の軸方向に長い溝等を採用することもできる。 As described above, the catheter assembly 10A according to the second embodiment can achieve the same effects as those of the catheter assembly 10 according to the first embodiment. In particular, the catheter assembly 10 </ b> A has a flow hole 142 in which the open body 136 is longer in the axial direction than the thickness of the blocking membrane 50. Therefore, in a state where the open body 136 is inserted into the plug slit 53 and the flow hole 142 is overlapped with the plug slit 53, the proximal end side hollow portion 22 b and the distal end side hollow portion 22 a communicate with each other through the flow hole 142. Therefore, the infusion agent can easily flow into the distal end side hollow portion 22a through the circulation hole 142. In addition, the distribution mechanism of the infusion agent by the open trunk | drum 136 is not limited to the flow hole 142 penetrated up and down, For example, the groove | channel etc. which are long in the axial direction of the open trunk | drum 136 can also be employ | adopted.
 また、カテーテル組立体10Aは、バネ部132がプラグ130に一体成形されていることで、部品点数を減らすことができ、製造コストや作業工数を削減することができる。要するに、カテーテル組立体10、10Aのプラグ30、130を押し戻す弾性部の構成は特に限定されるものではない。例えば、第1実施形態に係るプラグ30に第2実施形態に係るバネ部132を設けてもよい。また、弾性部を一体成形する部材は、プラグ30、130に限定されず、カテーテルハブ14、止血弁24又はシール部材26、150等でもよい。例えば、カテーテルハブ14に弾性部を設ける場合は、案内部34の内壁34aからプラグ30の先端面に向かって突出する弾性片(図示せず)とすればよい。また、弾性片は、弁配置部36やコネクタ接続部38に設けられ、プラグ30のフランジ部58に弾性的に接触する構成でもよい。また例えば、止血弁24(シール部材26)に弾性部を設ける場合は、止血弁24の基端部からプラグ30のフランジ部58に向けて弾性片を突出させればよい。 Further, since the spring part 132 is integrally formed with the plug 130, the catheter assembly 10A can reduce the number of parts, and can reduce the manufacturing cost and the work man-hour. In short, the configuration of the elastic portion that pushes back the plugs 30 and 130 of the catheter assemblies 10 and 10A is not particularly limited. For example, the spring portion 132 according to the second embodiment may be provided in the plug 30 according to the first embodiment. Further, the member for integrally forming the elastic portion is not limited to the plugs 30 and 130, and may be the catheter hub 14, the hemostasis valve 24, the seal members 26 and 150, or the like. For example, when an elastic portion is provided on the catheter hub 14, an elastic piece (not shown) that protrudes from the inner wall 34 a of the guide portion 34 toward the distal end surface of the plug 30 may be used. Further, the elastic piece may be provided in the valve arrangement portion 36 or the connector connection portion 38 and elastically contact the flange portion 58 of the plug 30. For example, when providing an elastic part in the hemostatic valve 24 (seal member 26), an elastic piece may be protruded from the base end part of the hemostatic valve 24 toward the flange part 58 of the plug 30.
 さらに、カテーテル組立体10Aは、閉塞頭部134と開放胴部136の厚みが同一であることで、プラグ用スリット53と相対的にプラグ30を変位させる際に、プラグ30の摺動抵抗を抑えてスムーズに移動させることができる。 Further, the catheter assembly 10 </ b> A suppresses the sliding resistance of the plug 30 when the plug 30 is displaced relative to the plug slit 53 because the closed head 134 and the open body 136 have the same thickness. Can be moved smoothly.
〔第3実施形態〕
 第3実施形態に係るカテーテル組立体10Bは、図14A及び図14Bに示すように、カテーテルハブ14の中空部22に配置される各部材の構成が第1及び第2実施形態に係るカテーテル組立体10、10Aと異なる。具体的には、このカテーテル組立体10Bに組み付けられるプラグ160は板状の弾性部材(板バネ)として構成されている。
[Third Embodiment]
As shown in FIGS. 14A and 14B, the catheter assembly 10B according to the third embodiment is configured such that the configuration of each member disposed in the hollow portion 22 of the catheter hub 14 is according to the first and second embodiments. Different from 10, 10A. Specifically, the plug 160 assembled to the catheter assembly 10B is configured as a plate-like elastic member (plate spring).
 また、プラグ160が板バネに構成されていることから、カテーテルハブ14内にバネ28(図2参照)を収容しない構成とすることができる。このため例えば、中空部22内には、第1実施形態に係る止血弁24と、第2実施形態に係るシール部材150が適宜の位置に配置され、これら止血弁24及びシール部材150と貫通するようにプラグ160が収容される。 Further, since the plug 160 is configured as a leaf spring, the spring 28 (see FIG. 2) cannot be accommodated in the catheter hub 14. For this reason, for example, the hemostasis valve 24 according to the first embodiment and the seal member 150 according to the second embodiment are disposed at appropriate positions in the hollow portion 22 and penetrate through the hemostasis valve 24 and the seal member 150. Thus, the plug 160 is accommodated.
 プラグ160は、第1実施形態に係るプラグ30に比べて容易に弾性変形するように充分に薄い状態で延び、案内部34、弁配置部36、コネクタ接続部38間をわたる軸方向長さを有する。詳細には、先端側から基端側に向かって、先端係止部162、中間変形部164及び基端受部166が設けられている。また、プラグ160の左右方向の幅は、プラグ用スリット53の左右方向(延在方向)の幅に略一致しており、先端係止部162、中間変形部164及び基端受部166は同じ幅に形成されている。 The plug 160 extends in a sufficiently thin state so as to be easily elastically deformed compared to the plug 30 according to the first embodiment, and has an axial length extending between the guide portion 34, the valve disposing portion 36, and the connector connecting portion 38. Have. Specifically, a distal end locking portion 162, an intermediate deformation portion 164, and a proximal end receiving portion 166 are provided from the distal end side toward the proximal end side. Further, the width in the left-right direction of the plug 160 is substantially equal to the width in the left-right direction (extending direction) of the plug slit 53, and the distal end locking portion 162, the intermediate deformation portion 164, and the base end receiving portion 166 are the same. It is formed in width.
 先端係止部162は、案内部34の内壁34aに係止される部分であり、図15A及び図15Bに示すように、下方向に湾曲するように形成されている。先端係止部162の湾曲度合い(曲率半径)は、基端受部166の丸角に比べて大きく形成されている。これにより、カテーテルハブ14内にプラグ160を組み付ける際には、先端係止部162をプラグ用スリット53に容易に挿入して、カテーテルハブ14内での引っ掛かりを抑えてスムーズに先端側まで入れ込むことができる。 The front end locking portion 162 is a portion that is locked to the inner wall 34a of the guide portion 34, and is formed to be bent downward as shown in FIGS. 15A and 15B. The degree of curvature (curvature radius) of the distal end locking portion 162 is formed larger than the round corner of the proximal end receiving portion 166. As a result, when the plug 160 is assembled into the catheter hub 14, the distal end locking portion 162 is easily inserted into the plug slit 53, and is smoothly inserted to the distal end side while being prevented from being caught in the catheter hub 14. be able to.
 また、先端係止部162は、幅方向中間部が切り欠かれることで、下方向に向かって一対の脚部162aが形成されている。一対の脚部162aの先端は、鋭角に形成され、案内部34のテーパ状に形成された内壁34aに引っ掛かり易くなっている。一対の脚部162aの間は、カテーテル12の内腔12aよりも幅広な逆U字状の谷部162bとなっており、内針16及び輸液剤が容易に通過可能に構成されている。 Further, the distal end locking portion 162 has a pair of leg portions 162a formed in the downward direction by notching the intermediate portion in the width direction. The tip ends of the pair of leg portions 162a are formed at an acute angle and are easily caught on the inner wall 34a formed in a tapered shape of the guide portion 34. A space between the pair of legs 162a is an inverted U-shaped valley 162b wider than the lumen 12a of the catheter 12, and the inner needle 16 and the infusion solution can be easily passed.
 なお、先端係止部162の形状は、特に限定されるものではなく、プラグ160が所定方向に弾性変形するようにプラグ160を係止する構成であればよい。例えば、先端係止部162は、湾曲せずに略直線状に延び、案内部34の内壁34aに係止されてもよい。また例えば、カテーテルハブ14は、先端側中空部22a内に図示しない係止用突起を突出形成(例えば、一体成形)して、先端係止部162が引っ掛かるように構成してもよい。 It should be noted that the shape of the tip locking portion 162 is not particularly limited as long as the plug 160 is locked so that the plug 160 is elastically deformed in a predetermined direction. For example, the distal end locking portion 162 may extend substantially linearly without being curved, and may be locked to the inner wall 34 a of the guide portion 34. Further, for example, the catheter hub 14 may be configured such that a locking projection (not shown) is projected (for example, integrally formed) in the distal end side hollow portion 22a so that the distal end locking portion 162 is hooked.
 中間変形部164は、先端係止部162の基端側に連なり、側面視で緩やかに円弧状を描くように形状記憶された部位である。この中間変形部164は、薄い板厚で軸方向に長尺に形成されることにより、比較的容易に弾性変形する。すなわち、中間変形部164は、板バネの面方向と直交する下方向に撓むように変形する。 The intermediate deformation portion 164 is a portion that is connected to the proximal end side of the distal end locking portion 162 and has a shape memorized so as to draw a gentle arc shape in a side view. The intermediate deformation part 164 is elastically deformed relatively easily by being formed thin in the axial direction with a thin plate thickness. That is, the intermediate deformation portion 164 is deformed so as to bend downward in a direction perpendicular to the surface direction of the leaf spring.
 カテーテル組立体10Bは、プラグ160の中間変形部164の弾性変形に基づき、プラグ用スリット53を下方向に開放する構成となっている。具体的には、中間変形部164の軸方向中間部の頂部164a付近が止血弁24の閉塞膜50に重なるように挿入される。プラグ160が弾性変形していない穿刺可能状態等では、挿入された中間変形部164は、閉塞膜50を閉塞する位置に(プラグ用スリット53の初期形成位置で開放作用を付与しないように)配置されている。一方、プラグ160が先端方向に押し込まれると、中間変形部164が弓なりにしなって、頂部164aが下方向へ変位し閉塞膜50を押し下げる。これにより、プラグ用スリット53が大きく開放される。 The catheter assembly 10B is configured to open the plug slit 53 downward based on the elastic deformation of the intermediate deformation portion 164 of the plug 160. Specifically, it is inserted so that the vicinity of the top portion 164 a of the intermediate portion in the axial direction of the intermediate deformable portion 164 overlaps the occlusion membrane 50 of the hemostasis valve 24. In the punctureable state where the plug 160 is not elastically deformed, the inserted intermediate deformation portion 164 is disposed at a position where the plugging membrane 50 is closed (so as not to provide an opening action at the initial formation position of the plug slit 53). Has been. On the other hand, when the plug 160 is pushed in the distal direction, the intermediate deformation portion 164 becomes a bow, and the top portion 164a is displaced downward to push down the blocking membrane 50. As a result, the plug slit 53 is largely opened.
 基端受部166は、中間変形部164の基端側に連なり、輸液チューブのコネクタ20が接触して押圧力を受ける部位であり、第1及び第2実施形態に係るフランジ部58、138に相当する。この基端受部166は、中間変形部164の基端側に対し略90°折り曲げられる。中間変形部164との連結箇所165は、丸角に形成されているが、その曲率半径は先端係止部162に比べて小さい。 The proximal end receiving portion 166 is connected to the proximal end side of the intermediate deformable portion 164 and is a portion that receives the pressing force when the connector 20 of the infusion tube comes into contact with the flange portions 58 and 138 according to the first and second embodiments. Equivalent to. The base end receiving portion 166 is bent by approximately 90 ° with respect to the base end side of the intermediate deformation portion 164. The connection portion 165 with the intermediate deformation portion 164 is formed in a rounded corner, but its radius of curvature is smaller than that of the tip locking portion 162.
 また、基端受部166も、先端係止部162と同様に、幅方向中間部が切り欠かれることで、下方向に向かって一対の脚部166aが形成されている。一対の脚部166aの間は、内針16を通すと共にコネクタ20が接触した状態で、コネクタ20の内腔に連通する幅広な逆U字状の谷部166bとなっている。 Also, the base end receiving portion 166 has a pair of leg portions 166a formed in the downward direction by notching the intermediate portion in the width direction, similarly to the distal end locking portion 162. Between the pair of leg portions 166a, a wide inverted U-shaped valley portion 166b communicating with the inner cavity of the connector 20 in a state where the inner needle 16 is passed and the connector 20 is in contact with each other is formed.
 以上のプラグ160を構成する材料は、特に限定されるものではないが、金属材料又は樹脂材料を適用するとよい。金属材料としては、例えば、Ni-Ti系合金のような擬弾性合金(超弾性合金を含む)、形状記憶合金、ステンレス鋼、コバルト系合金、金、白金のような貴金属、タングステン系合金、炭素系材料等が挙げられる。或いは、プラグ160は、止血弁24よりも硬く、ゴム性を有する樹脂材料を適用してもよい。 Although the material constituting the plug 160 is not particularly limited, a metal material or a resin material may be applied. Examples of metal materials include pseudoelastic alloys (including superelastic alloys) such as Ni-Ti alloys, shape memory alloys, stainless steel, cobalt alloys, noble metals such as gold and platinum, tungsten alloys, carbon Examples thereof include system materials. Alternatively, the plug 160 may be made of a resin material that is harder than the hemostasis valve 24 and has a rubber property.
 図14A及び図14Bに戻り、カテーテル組立体10Bは、穿刺可能状態を構成するために、プラグ160を止血弁24のプラグ用スリット53に挿入し、中間変形部164の頂部164a付近がプラグ用スリット53に重なる位置に配置する。この状態では、先端係止部162が案内部34の内壁34aにちょうど引っ掛かる。プラグ160と止血弁24は、相互に無理な作用力をかけずに配置されるため、中空部22を良好に閉塞することができる。また、内針用スリット52にも内針16が挿通される。 14A and 14B, the catheter assembly 10B is configured so that the plug 160 is inserted into the plug slit 53 of the hemostasis valve 24, and the vicinity of the top portion 164a of the intermediate deformable portion 164 is the plug slit in order to configure the punctureable state. It is arranged at a position overlapping 53. In this state, the front end locking portion 162 is just hooked on the inner wall 34a of the guide portion 34. Since the plug 160 and the hemostasis valve 24 are disposed without applying an excessive force to each other, the hollow portion 22 can be satisfactorily closed. The inner needle 16 is also inserted into the inner needle slit 52.
 第3実施形態に係るカテーテル組立体10Bは、基本的には以上のように構成されるものであり、以下その作用効果について説明する。 The catheter assembly 10B according to the third embodiment is basically configured as described above, and the operation and effect thereof will be described below.
 カテーテル組立体10Bも、第1及び第2実施形態に係るカテーテル組立体10、10Aと同様の操作がなされる。すなわち、上記の穿刺可能状態で、カテーテル組立体10Bは、ユーザの操作下にカテーテル12及び内針16が患者に穿刺され、その後内針16が引き抜かれる。内針16の引き抜き時には、止血弁24のプラグ用スリット53にプラグ160が挿入されていることにより、プラグ用スリット53を確実に閉塞する。このため、中空部22に血液が流入しても、止血弁24は血液の漏出を良好に遮断することができる。 The catheter assembly 10B is also operated in the same manner as the catheter assemblies 10 and 10A according to the first and second embodiments. That is, in the puncture enabled state, in the catheter assembly 10B, the catheter 12 and the inner needle 16 are punctured by the patient under the operation of the user, and then the inner needle 16 is pulled out. When the inner needle 16 is pulled out, the plug slit 53 is reliably closed by inserting the plug 160 into the plug slit 53 of the hemostasis valve 24. For this reason, even if blood flows into the hollow portion 22, the hemostasis valve 24 can satisfactorily block blood leakage.
 次に、図16Aに示すように輸液チューブのコネクタ20をカテーテルハブ14に挿入する。コネクタ20の挿入時には、コネクタ20の先端面がプラグ160の基端受部166に接触してプラグ160を先端方向に押し出す。これによりプラグ160の中間変形部164が軸方向に押し込まれ、先端係止部162が引っ掛かっていることで、中間変形部164の板面が下方向にしなるように弾性変形する。 Next, the infusion tube connector 20 is inserted into the catheter hub 14 as shown in FIG. 16A. When the connector 20 is inserted, the distal end surface of the connector 20 contacts the proximal end receiving portion 166 of the plug 160 and pushes the plug 160 in the distal direction. As a result, the intermediate deformation portion 164 of the plug 160 is pushed in the axial direction, and the tip locking portion 162 is hooked, so that the plate surface of the intermediate deformation portion 164 is elastically deformed downward.
 そして、コネクタ20がコネクタ接続部38に対し嵌合する位置では、図16Bに示すように、プラグ160の頂部164aが大きく変位した状態となり、中間変形部164の板面に押されたプラグ用スリット53が大きく開放する。よって、コネクタ20から供給された輸液剤は、基端受部166の谷部166bを通って基端側中空部22bに流入し、さらにプラグ用スリット53を通って先端側中空部22aに流入する。 Then, at the position where the connector 20 is fitted to the connector connecting portion 38, as shown in FIG. 16B, the top portion 164a of the plug 160 is greatly displaced, and the plug slit pressed against the plate surface of the intermediate deformable portion 164. 53 greatly opens. Therefore, the infusion agent supplied from the connector 20 flows into the proximal end side hollow portion 22b through the valley portion 166b of the proximal end receiving portion 166, and further flows into the distal end side hollow portion 22a through the plug slit 53. .
 また、止血弁24よりも先端側では、平板状の中間変形部164の周囲を回り込むように輸液剤を流出させる。このため、先端側中空部22a内での滞留領域84(図8参照)の発生を抑制することができる。先端側中空部22aに流入した輸液剤は、カテーテル12の内腔12aに容易に導かれて、患者の血管内に流入する。 Further, on the tip side of the hemostasis valve 24, the infusion solution is caused to flow around the flat intermediate deformation portion 164. For this reason, generation | occurrence | production of the retention area | region 84 (refer FIG. 8) in the front end side hollow part 22a can be suppressed. The infusate that has flowed into the distal end side hollow portion 22a is easily guided to the lumen 12a of the catheter 12 and flows into the blood vessel of the patient.
 さらに、輸液剤の交換等によりカテーテルハブ14からコネクタ20を後退移動すると、図17A及び図17Bに示すように、中間変形部164が弾性的に復元する。つまり、下方向に変位していた頂部164a付近が上方向に自動的に戻り、プラグ用スリット53が再閉塞する。 Furthermore, when the connector 20 is moved backward from the catheter hub 14 by exchanging an infusion solution or the like, as shown in FIGS. 17A and 17B, the intermediate deformable portion 164 is elastically restored. That is, the vicinity of the top portion 164a that has been displaced downward automatically returns upward, and the plug slit 53 is closed again.
 プラグ用スリット53は、中間変形部164により隙間なく密閉され、止血弁24とプラグ160は中空部22を強固に閉塞する。従って、止血弁24の基端側中空部22bに血液が漏れることを良好に回避することができる。 The plug slit 53 is hermetically sealed by the intermediate deformation portion 164, and the hemostasis valve 24 and the plug 160 firmly close the hollow portion 22. Accordingly, it is possible to favorably avoid blood from leaking into the proximal end side hollow portion 22b of the hemostasis valve 24.
 以上のように、第3実施形態に係るカテーテル組立体10Bでも、第1及び第2実施形態に係るカテーテル組立体10、10Aと同様の効果を得ることができる。特に、プラグ用スリット53に常に挿入されるプラグ160の中間変形部164が、プラグ用スリット53の左右方向と直交する上下方向に弾性変形可能であることで、中間変形部164の変形に伴いプラグ用スリット53を容易に開放することができる。 As described above, the catheter assembly 10B according to the third embodiment can achieve the same effects as those of the catheter assemblies 10, 10A according to the first and second embodiments. In particular, since the intermediate deformation portion 164 of the plug 160 that is always inserted into the plug slit 53 can be elastically deformed in the vertical direction perpendicular to the left-right direction of the plug slit 53, the plug is deformed along with the deformation of the intermediate deformation portion 164. The slit 53 can be easily opened.
 また、プラグ160の基端に基端受部166が形成されていることで、輸液チューブのコネクタ20からの押圧力により板状の中間変形部164を簡単に変形させて、プラグ用スリット53を開放することができる。なお、プラグ160の両端部の形状は特に限定されず、例えば、第1又は第2実施形態に係るフランジ部58、138を溶接等により溶着してもよい。 Further, since the base end receiving portion 166 is formed at the base end of the plug 160, the plate-shaped intermediate deformation portion 164 can be easily deformed by the pressing force from the connector 20 of the infusion tube, and the plug slit 53 is formed. Can be opened. In addition, the shape of the both ends of the plug 160 is not specifically limited, For example, you may weld the flange parts 58 and 138 which concern on 1st or 2nd embodiment by welding etc.
 上記において、本発明について好適な実施形態を挙げて説明したが、本発明は前記実施形態に限定されるものではなく、本発明の要旨を逸脱しない範囲において、種々の改変が可能なことは言うまでもない。 In the above description, the present invention has been described with reference to preferred embodiments. However, the present invention is not limited to the above-described embodiments, and various modifications can be made without departing from the scope of the present invention. Yes.

Claims (8)

  1.  カテーテル(12)と、
     前記カテーテル(12)を保持し、前記カテーテル(12)の孔部(12a)に連通する中空部(22)を有するハブ(14)と、
     前記孔部(12a)及び前記中空部(22)を挿通可能な内針(16)と、
     前記中空部(22)に変位自在に配置される挿通部材(30、130、160)と、
     前記中空部(22)に設けられる弁体(24)と、を備え、
     前記弁体(24)は、前記内針(16)が挿通される内針用スリット(52)と、前記挿通部材(30、130、160)が挿通される挿通部材用スリット(53)と、を別に有する
     ことを特徴とするカテーテル組立体(10、10A、10B)。
    A catheter (12);
    A hub (14) holding the catheter (12) and having a hollow portion (22) communicating with the hole (12a) of the catheter (12);
    An inner needle (16) that can be inserted through the hole (12a) and the hollow portion (22);
    An insertion member (30, 130, 160) disposed in the hollow portion (22) so as to be displaceable;
    A valve body (24) provided in the hollow portion (22),
    The valve body (24) includes an inner needle slit (52) through which the inner needle (16) is inserted, and an insertion member slit (53) through which the insertion member (30, 130, 160) is inserted. A catheter assembly (10, 10A, 10B).
  2.  請求項1記載のカテーテル組立体(10、10A)において、
     前記挿通部材(30、130)は、前記挿通部材用スリット(53)を閉塞する閉塞部(54、134)と、前記閉塞部(54、134)の基端側に連なり該閉塞部(54、134)に対し形状又は位相が異なることで前記挿通部材用スリット(53)を開放する開放部(56、136)と、を備え、
     前記挿通部材用スリット(53)には、前記閉塞部(54、134)又は前記開放部(56、136)のいずれか一方が常に挿入されている
     ことを特徴とするカテーテル組立体(10、10A)。
    The catheter assembly (10, 10A) according to claim 1,
    The insertion member (30, 130) is connected to a closing portion (54, 134) that closes the slit (53) for the insertion member, and a base end side of the closing portion (54, 134). 134) and opening portions (56, 136) that open the slits (53) for the insertion member by being different in shape or phase,
    One of the blocking portions (54, 134) and the opening portions (56, 136) is always inserted in the insertion member slit (53). The catheter assembly (10, 10A) ).
  3.  請求項2記載のカテーテル組立体(10)において、
     前記開放部(56)の断面形状は、前記閉塞部(54)の断面形状に略相似し、且つ前記閉塞部(54)に対し前記挿通部材(30)の軸心回りに位相が略90°ずれている
     ことを特徴とするカテーテル組立体(10)。
    Catheter assembly (10) according to claim 2,
    The cross-sectional shape of the open portion (56) is substantially similar to the cross-sectional shape of the closed portion (54), and the phase around the axis of the insertion member (30) is approximately 90 ° with respect to the closed portion (54). A catheter assembly (10) characterized in that it is displaced.
  4.  請求項2記載のカテーテル組立体(10A)において、
     前記開放部(136)は、前記弁体(24)の前記挿通部材用スリット(53)が設けられた閉塞膜(50)の肉厚よりも軸方向に長い流通穴(142)を有する
     ことを特徴とするカテーテル組立体(10A)。
    The catheter assembly (10A) according to claim 2,
    The open part (136) has a flow hole (142) that is longer in the axial direction than the thickness of the blocking membrane (50) provided with the slit (53) for the insertion member of the valve body (24). Feature catheter assembly (10A).
  5.  請求項4記載のカテーテル組立体(10A)において、
     前記閉塞部(134)と前記開放部(136)は、前記挿通部材用スリット(53)の延在方向と直交する方向の厚みが同一である
     ことを特徴とするカテーテル組立体(10A)。
    The catheter assembly (10A) according to claim 4,
    The catheter assembly (10A), wherein the blocking part (134) and the opening part (136) have the same thickness in a direction perpendicular to the extending direction of the insertion member slit (53).
  6.  請求項1記載のカテーテル組立体(10B)において、
     前記挿通部材用スリット(53)には、前記挿通部材(160)が常に挿入され、
     前記挿通部材(160)は、前記挿通部材用スリット(53)の延在方向と直交する方向に弾性変形可能な変形部(164)を有する
     ことを特徴とするカテーテル組立体(10B)。
    The catheter assembly (10B) of claim 1,
    The insertion member (160) is always inserted into the insertion member slit (53),
    The insertion member (160) includes a deformable portion (164) that can be elastically deformed in a direction orthogonal to the extending direction of the insertion member slit (53). The catheter assembly (10B).
  7.  請求項6記載のカテーテル組立体(10B)において、
     前記変形部(164)は、板状に形成されて軸方向に延在し、
     前記挿通部材(160)の一端には、前記変形部(164)に湾曲して連なり前記ハブ(14)に接続されたコネクタ(20)からの押圧力を受けることが可能な受部(166)が形成されている
     ことを特徴とするカテーテル組立体(10B)。
    The catheter assembly (10B) according to claim 6,
    The deformation part (164) is formed in a plate shape and extends in the axial direction,
    At one end of the insertion member (160), a receiving portion (166) that is curved and connected to the deformable portion (164) and can receive a pressing force from a connector (20) connected to the hub (14). A catheter assembly (10B) characterized in that is formed.
  8.  請求項1記載のカテーテル組立体(10、10A、10B)において、
     前記内針用スリット(52)と前記挿通部材用スリット(53)は平行に形成され、且つ前記挿通部材用スリット(53)の切込幅が前記内針用スリット(52)の切込幅よりも長い
     ことを特徴とするカテーテル組立体(10、10A、10B)。
    The catheter assembly (10, 10A, 10B) according to claim 1,
    The inner needle slit (52) and the insertion member slit (53) are formed in parallel, and the cut width of the insertion member slit (53) is larger than the cut width of the inner needle slit (52). A catheter assembly (10, 10A, 10B) characterized in that it is also long.
PCT/JP2015/054541 2014-03-20 2015-02-19 Catheter assembly WO2015141365A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2016508605A JPWO2015141365A1 (en) 2014-03-20 2015-02-19 Catheter assembly

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014-058085 2014-03-20
JP2014058085 2014-03-20

Publications (1)

Publication Number Publication Date
WO2015141365A1 true WO2015141365A1 (en) 2015-09-24

Family

ID=54144344

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2015/054541 WO2015141365A1 (en) 2014-03-20 2015-02-19 Catheter assembly

Country Status (2)

Country Link
JP (1) JPWO2015141365A1 (en)
WO (1) WO2015141365A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019063133A (en) * 2017-09-29 2019-04-25 テルモ株式会社 Catheter assembly
CN110153670A (en) * 2019-05-24 2019-08-23 江天云 A kind of connector nut cap kludge of perfusion tube

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010142363A (en) * 2008-12-17 2010-07-01 Nipro Corp Medical valve
JP2012517326A (en) * 2009-02-11 2012-08-02 ベクトン・ディキンソン・アンド・カンパニー System and method for providing a washable catheter assembly
WO2013047205A1 (en) * 2011-09-28 2013-04-04 テルモ株式会社 Catheter assembly

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9155864B2 (en) * 2011-10-06 2015-10-13 Becton, Dickinson And Company Multiple use blood control valve with center and circumferential slits

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010142363A (en) * 2008-12-17 2010-07-01 Nipro Corp Medical valve
JP2012517326A (en) * 2009-02-11 2012-08-02 ベクトン・ディキンソン・アンド・カンパニー System and method for providing a washable catheter assembly
WO2013047205A1 (en) * 2011-09-28 2013-04-04 テルモ株式会社 Catheter assembly

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019063133A (en) * 2017-09-29 2019-04-25 テルモ株式会社 Catheter assembly
CN110153670A (en) * 2019-05-24 2019-08-23 江天云 A kind of connector nut cap kludge of perfusion tube
CN110153670B (en) * 2019-05-24 2023-12-15 江天云 Connector cap assembly machine of infusion tube

Also Published As

Publication number Publication date
JPWO2015141365A1 (en) 2017-04-06

Similar Documents

Publication Publication Date Title
JP6564078B2 (en) Catheter assembly with seal member
JP6067567B2 (en) Catheter assembly
JP6925319B2 (en) Catheter devices with valves and related methods
JP6138921B2 (en) Catheter assembly
US8192404B2 (en) Indwelling needle assembly
JP5253385B2 (en) Indwelling needle assembly
WO2013137348A1 (en) Catheter assembly
EP3662959A1 (en) Indwelling needle provided with hemostatic valve, and indwelling needle assembly
WO2015141365A1 (en) Catheter assembly
JP2013070870A (en) Catheter assembly
WO2015141366A1 (en) Catheter assembly
JP5578488B2 (en) Indwelling needle assembly
JP4873929B2 (en) Indwelling needle assembly
JP6129825B2 (en) Catheter assembly
JP6827698B2 (en) Catheter assembly
JP4723419B2 (en) Indwelling needle assembly
JP2019193752A (en) Valved needle assembly
JP6166358B2 (en) Catheter assembly

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15764855

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2016508605

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15764855

Country of ref document: EP

Kind code of ref document: A1